SRC TR

- 12

- 073

HPV 2 TEST RULE DATA ADEQUACY REVIEW : SEPTEMBER 2012 UPD ATE (FINAL )

1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS RN 4719

- 04

- 4

Prepared by:

Jennifer Rayner

, Teresa Manyin, Justine Von Runnen, Ashlee Aldridge,

and William L. Richards

Chemical, Biological and Environmental Center

SRC, Inc.
7502 Round Pond Road North Syracuse, NY 13212

Contract No. EP

- W

- 09

- 027
Task FG007.2.009.00 1

Submitted to:

OCSPP/OPPT/RAD (7403M) U.S. Environmental Protection Agency 1200 Pennsylvania Avenue Washington, D.C. 20460

Debra Milligan, Project Officer Meena Sonawane, Work Assignment Manager David Brooks, Alternate Work Assignment Manager

September 14, 2012Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

i TABLE OF CONTENTS

A. SOURCE MATERIAL USED FOR ASSESSMENT

................................ .............................. 1

B. EVALUATI NG DATA ADEQUACY

................................ ................................ ..................... 1

C

. SUMMARY OF DATA ADEQUACY FOR TESTING REQUIRED BY TEST RULE

........ 1

D. DATA FOR SIDS ENDPOINTS

................................ ................................ .............................. 5

D

- 1. Acute Toxicity to Fish

................................ ................................ ................................ ....... 5

D

- 2. Acute Toxicity to Aquatic Invertebrates

................................ ................................ .......... 30

D

- 3. Toxicity to Aquatic Plants

................................ ................................ ............................... 3 5

D

- 4. Acute Toxicity

................................ ................................ ................................ .................. 46

D

- 5. Repeated

- Dose Toxicity

................................ ................................ ................................ ... 59

D

- 6. Genetic Toxicity

– Gene Mutation

................................ ................................ ................... 68

D

- 7. Genetic Toxicity

– Chromosomal Aberrations

................................ ................................ 80

D

- 9. Reproductive Toxicity

................................ ................................ ................................ ...... 84

D

- 10. Developmental Toxicity

................................ ................................ ................................ . 85

E. SUPPLEMENTAL DATA (NON

- SIDS ENDPOINTS)

................................ ........................ 88

E

- 1. Genetic Toxicity

– Other

................................ ................................ ................................ .. 88

E

- 2. Skin Irritation

................................ ................................ ................................ .................... 93

E

- 3. Eye Irritation

................................ ................................ ................................ ..................... 99

E

- 4. Skin Sensitization

................................ ................................ ................................ ........... 103

F. DATA ADEQUACY SUMMARY TABLE

................................ ................................ ......... 107Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

1 A. SOURCE MATERIAL USED FOR ASSESSMENT

This document evaluates an algal inhibition test study report, which was submitted to EPA on July 3 0, 2012 by the MEA Triazine Consortium in response to the C6 testing requirement for 1,3,5

- triazine

- 1,3,5(2H,4H,6H)

- triethanol (CASRN 4719

– 04

– 4) in the final test rule, “Testing of Certain High Production Volume Chemicals; Second Group of Chemicals” (76 FR 1067, January 7, 2011; referred to here in as HPV2). The C6 requirement consists of Toxicity to Plants (Algae) testing, following ASTM guideline E 1218

- 04 ε1

. The toxicity to algae stud y submitted by the
MEA Triazine Consortium is evaluated for adequacy herein

. This report also contains data for other ecological and toxicological endpoints that were evaluated previously by EPA and, therefore, provides an update of the data adequacy assessment previously compiled for CASRN
4719

- 04

- 4 in April 2011

.

B. EVALUATING DATA ADEQUACY

Data for the HPV2 test rule

- required endpoint, as well as available data for other SIDS toxicity endpoints, are evaluated for adequacy in Section D . Each study was summarized according to a standard format and assigned a Klimisch reliability code based on its scientific merit and conduct, using professional judgment. To determine whether data were adequate to satisfy SIDS endpoints, study details were compared to current standard test guidelines to establish whether the study met current testing requirements. Studies for a common endpoint are grouped together in the document and an endpoint adequacy assessment is provided near the top of the first page of the summaries for that endpoint. If the data available for the endpoint we re determined to be inadequate, a basis for that conclusion is supplied. Additional data for non

- SIDS toxicity endpoints (“supplemental” data) are reviewed in Section E . A table summarizing data availability/adequacy for each SIDS endpoint is included on the last pa ge of this document (Section F)

.

C

. SUMMARY OF DATA ADEQUACY FOR TESTING REQUIRED BY TEST RULE

The submitted algae study is summarized and evaluated in detail on p p

. 35

- 41 of this report. The following deficiencies in the algae study were noted:

(1) T he study authors measured the concentrations of the primary degradation products (monoethanolamine and formaldehyde) and did not measure the concentration of the parent test compound ( 1,3,5

- triazine

- 1,3,5(2H,4H,6H)

- triethanol ; CASRN 4719

- 04

- 4 ). This analytical testing scheme differs from the proposed methodology in the s tud y plan submitted by SOCMA ( the MEA Triazine Consortium ) on January 6, 2012; th is study plan indicated that verification of the test concentrations would be achieved by measurements of the parent test item at 0 hours and measurement of the degradation products at 0 and 96 hours. EPA had approved this proposed plan for verification of test concentrations.

Despite the fact that the algae test did not include measurements of the parent test compound, the measured concentrations of the degradation products appear to suggest that complete degradation
of CASRN 4719

- 04

- 4 was achieved quick ly. The measured concentrations of monoethanolamine and formaldehyde at the initiation of exposure (time = 0 hours) were similarFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

2 to the expected concentrations of these degradation products based on nominal concentrations of
CASRN 4719

- 04

- 4, assuming that CASRN 4719

- 04

- 4 degraded completely to form monoethanolamine and formaldehyde . Tables 1 and 2 (below) show comparisons of the
measured and nominal concentrations for monoethanolamine and formaldehyde, respectively.

Table 1. Concentrations of monoethano lamine in test medium.

Sample Nominal

Concentration
of CASRN
4719

- 04

- 4 (mg a.i./L) 1 Nominal

Concentration
of Mono

ethanolamine (mg/L) 2 Measured

Concentration
of Mono

ethanolamine (mg/L) Measured

Concentration
of Mono

ethanolamine
as Percent of
Nominal Calculated

Concentration
of CASRN
4719

- 04

- 4
Based on
Measurement (mg/L) 3

0 hours 1.0 0.84 0.518 62 0.62

3.2 2.67 3.17 119 3.79
10 8.36 11.4 136 13.64
32 26.74 34.7 130 41.52
100 83.56 91.9 110 109.98
96 hours (opened every
24 h to obtain
cell density samples) 1.0 0.84 0.343 41 0.41

3.2 2.67 2.82 105 3.37
10 8.36 7.6 91 9.09
32 26.74 19.6 73 23.45
100 83.56 56.8 68 67.97
96 hours (unopened) 1.0 0.84 0.373 45 0.45

3.2 2.67 2.68 100 3.21
10 8.36 7.61 91 9.11
32 26.74 19.8 74 23.69
100 83.56 57.7 69 69.05

1 a .i. = active ingredient (concentration adjusted for other components in test substance)

2 Nominal concentration of monoethanol amine is calculated from the nominal concentration of
CASRN 4719

- 04

- 4 and assumes complete degradation of each mole of CASRN 4719

- 04

- 4 to produce 3 moles of monoethanolamine and 3 moles of formaldehyde.

3 Concentration of 4719

- 04

- 4 was calculated from the measured concentration of
monoethanolamine and assumes that each mole of CASRN 4719

- 04

- 4 produced 3 moles of
monoethanolamine.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

3 Table 2 . Concentrations of formaldehyde in test medium.

Sample Nominal

Concentration
of CASRN
4719

- 04

- 4 (mg a.i./L) 1 Nominal

Concentration
of Formaldehyde (mg/L) 2 Measured

Concentration
of
F ormaldehyde (mg/L) Measured

Concentration
of
F ormaldehyde
as Percent of
Nominal Calculated

Concentration
of CASRN
4719

- 04

- 4
Based on
Measurement (mg/L) 3

0 hours 1.0 0.41 0.482 117 1.17

3.2 1.31 1.5 114 3.65
10 4.11 4.21 102 10.25
32 13.15 15 114 36.51
100 41.08 43.8 107 106.61
96 hours (opened every
24 h to obtain cell density samples) 1.0 0.41 0.11 27 0.27

3.2 1.31 0.429 33 1.04
10 4.11 2.96 72 7.20
32 13.15 10.2 78 24.83
100 41.08 30.5 74 74.24
96 hours (unopened) 1.0 0.41 0.129 31 0.31

3.2 1.31 0.511 39 1.24
10 4.11 2.95 72 7.18
32 13.15 8.53 65 20.76
100 41.08 27 66 65.72

1 a.i. = active ingredient (concentration adjusted for other components in test substance)

2 Nominal concentration of formaldehyde is calculated from the nominal concentration of
CASRN 4719

- 04

- 4 and assumes complete degradation of each mole of CASRN 4719

- 04

- 4 to produce 3 moles of monoethanolamine and 3 moles of formaldehyde.

3 Concentration of 4719

- 04

- 4 was calculated from the measu red concentration of formaldehyde
and assumes that each mole of CASRN 4719

- 04

- 4 produced 3 moles of formaldehyde

.

(2) The study authors calculated t he EC 50 values based on nominal test concentrations . In general, if measured concentrations indicate that exposure concentrations were not maintained within ± 20% of nominal values, the use of mean measured (rather than nominal) concentrations
to calculate EC 50 values is preferred.

At initiation of exposure (time = 0 hours) , the measured concentrations of mo noethanolamine and formaldehyde were 62

- 136% and 102

- 117% of nominal (expected) concentrations, respectively. At the end of exposure (time = 96 hours), the measured concentrations of monoethanolamine and formaldehyde were 41

- 105 % and 27

- 78 % of nominal (ex pected) concentrations, respectively . Thus, the measured concentrations of monoethanolamine and formaldehyde both demonstrated variations outside the range of ± 20% of nominal values during the exposure period , with concentrations of formaldehyde showing a higher degree of variability
than those of monoethanolamine

. The variation in concentrations could have been the result of uptake by algae cells and/or reactions between monoethanolamine and formaldehyde to form other chemical compounds.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

4 Nonetheless, t he measured concentration s of monoethanolamine displayed a relative ly low degree of variation (measured concentrations were 91

- 1 36 % of nominal concentrations) at the
nominal test concentration s of 3.2 and 10 mg a.i./L. Since the 96

- hour EC 50 values presented for growth rate, yield, and biomass (4.2, 3.2, and 3.3 mg/L, respectively) were within the nominal
concentration range of 3.2 to 10 mg a.i./L

, they are likely to represent reasonable approximations
of the values that would be obtained if measured concentrations had been used to calculate EC 50 values (i.e., by using calculated concentrations of CASRN 4719

- 04

- 4 that correspond to measured concentrations of degradation products as shown in Tables 1 and 2, above)

.

(3) The complete composition of the test substance is not clearly stated in the submitted study report. The “Certificate of Analysis” in Appendix 1 does not define the complete composition of
the test substance . A purity of 77.5% is supplied on page 7 and Appendix 4 indi cates that the test substance contained 22.5% water, suggesting that water was the only impurity were present in the test compound. The “Certificate of Analysis” indicates that excess monoethanolamine (0.02 mole s ) was used in the production process; howev er, the excess monoethanolamine appears to amount to <1% of the total composition of the test substance. Since total im purit ies other than water appear to be <1%, the test substance is acceptable.

Conclusions: Despite the study deficiencies noted above, the a lgae toxicity data supplied on July 30 , 2012 by the MEA Triazine Consortium were considered adequate to satisfy the T oxicity

to P lants ( Algae) C6 test requirement for CASRN 4719

- 04

- 4 in the HPV2 test rule

.

The re are no d ata gaps remain ing for any SI DS endpoints.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

5 D . DATA FOR SIDS ENDPOINTS

D

- 1. Acute Toxicity to Fish

Summary of endpoint: Adequate

Study 1: Acute toxicity study in rainbow trout ( Davis and Kernaghan, 1994)

Title: Acute Toxicity to Rainbow Trout, Oncorhynchus mykiss , Under Flow

- through Test
Conditions

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 83.8% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 16.2%
unidentified

Remarks: Also referred to as Triazine and Shaughnessy No. 083301

METHOD

Method/guideline followed: OPP 72

- 1(A)

Test type: Acute Toxicity Test for Freshwater Fish, Rainbow Trout ( Oncorhynchus mykiss ),
flow

- through

GLP compliant?: Not specified

Year study was performed: 1994

Test species: Rainbow trout ( Oncorhynchus mykiss ), obtained from Mt. Lassen Trout Farms, Red Bluff, CA

Analytical monitoring: Yes

Exposure duration: 96 hours

Concentrations tested: Nominal: 15.6, 25.9, 43.2, 72.0, and 120 mg a.i./L; mean measured: 13.8, 26.6, 44.5, 73.4, and 119 mg a.i./L

Test method/conditions remarks: Rainbow trout were fed salmon starter and commercial flake food daily throughout the holding period. During the 48 hours immediately prior to initiation of
the 96

- hour exposure, mortality was 0 and fish were not fed. Rainbow trout ranged from 40 to 55 mm standard length and from 0.81 to 2.21 g wet weight as measured from the control at test
termination.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

6 The flow

- through te st was conducted in 23

- L tanks which maintained a constant water volume of approximately 15.3 L and a water height of 13 cm. The diluter (proportional vacuum

- siphon) cycled at an average of 5.0 cycles per hour. Organism loading was calculated to be 0.14 g/L/day, with a maximum loading at any point in time of 1.6 g/L.

Dilution water was municipal water, which was vigorously aerated to remove chlorine, then passed through activated carbon beds before being pumped into the laboratory. The water was

re

- aera ted prior to use. The dilution water was a moderately hard freshwater with a mean hardness of 52 mg CaCO 3 /L, mean alkalinity of 16 mg CaCO 3 /L, and a mean specific conductivity of 428 μmhos/cm.

A range

- finding test was conducted to determine the concentra tion range for the definitive test. The nominal concentrations for the definitive test were: 15.6, 25.9, 43.2, 72.0, and 120 mg a.i./L. No solvent was utilized to solubilize the test material as Triazine is completely miscible in water.

Twenty rainbow trout were randomly distributed in the treatment and control chambers of the
flow

- through test system. Survival of the trout was monitored daily and any dead fish were removed. Any abnormalities in the behavior or physical appearance of rainbow trout wer e also noted. Test solutions were gently aerated during the test.

Test water quality was monitored daily during the test. Water temperature was measured in the dilution water control hourly during the test and ranged from 11.1 to 13.8 °C. Specific
cond uctivity, total alkalinity, and total hardness of the dilution water were measured at test initiation and termination in the control container. Dissolved oxygen and pH were measured daily in all test solutions with surviving fish.

Water samples were collected from the controls and all five test solutions at test initiation, day 2, and termination to verify actual test concentrations. Mean measured concentrations were 13.8, 26.6, 44.5, 73.4, and 119 mg a.i./L.

RESULTS

Endpoint val ue(s): The 96

- hour LC 50 for rainbow trout was > 119 mg a.i./L. The NOEC was 119 mg a.i./L.

Results remarks: Mortality of rainbow trout exposed for 96 hours to Triazine was zero at all concentrations tested. No mortality occurred in the dilution water control. The 96

- hour LC 50 was greater than 119 mg a.i./L. The NOEC was 119 mg a.i./L, the highest concentration tested, based on a lack of mortality and a lack of sublethal effects at this test concentration and all test
concentrations.

CONCLUSIONS

The 96

- hour LC 50 for rainbow trout was > 119 mg a.i./L, based on a lack of mortality and sublethal effects at the highest dose tested.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

7 STUDY RELIABILITY

[1] Reliable without restrictions. This study was classified as “core” by U.S. EPA’s Office of
Pesticid e Programs.

REFERENCE

Davis, J.W., and Kernaghan, N.J. 1994. Acute Toxicity to Rainbow Trout, Oncorhynchus mykiss

, Under Flow

- through Test Conditions. Performing Laboratory: Toxikon Environmental Sciences, Jupiter, FL. Submitted by the Triazine Joint Venture, c/o Buckman Laboratories International, Inc., Memphis, TN. U.S. EPA MRID No. 431431

- 01.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

8 Study 2: Acute toxicity test in sheepshead minnow (Ward, 1994)

Title: Acute Toxic ity to the Sheepshead Minnow ( Cyprinodon variegatus ), Under Flow

- through
Test Conditions

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 83.8% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 16.2%
unidentified

Remarks: Also referred to as Triazine and Shaughnessy No. 083301

METHOD

Method/guideline followed: OPP 72

- 3(A)

Test type: Acute Toxicity Test for Estuarine/Marine Fish, Sheepshead Minnow ( Cyprinodon variegatus ), flow

- through

GLP compliant?: Yes

Year study was performed: 1994

Test species: Juvenile s heepshead minnows ( C. variegatus ), obtained from Toxikon Sciences, Jupiter, FL; age: 8 weeks; length: 18

- 24 mm; wet weight: 0.14

- 0.61 g

Analytical monitoring: Yes

Exposure duration: 96 hours

Concentrations tested: Nominal: 15.6, 25.9, 43.2, 72.0 and 120 mg a.i./L ; mean measured: 11.8, 23.8, 38.9, 70.9 and 118 mg a.i./L

Test method/conditions remarks: Juvenile sheepshead minnows (8 weeks old), obtained from Toxicon Sciences, were initially raised on a diet of live brine shrimp nauplii and later transferred to a diet of flake flood and frozen brine shrimp. During the 48 hours prior to testing, the minnows were not fed. The minnows ranged from 18 to 24 mm in length and from 0.14 to 0.61 g wet weight, as determined from the control fish at test termination.

The flow

- through test was conducted in 23

- L tanks which maintained a constant water volume of approximately 15.3 L and a water height of 13 cm. The dilu ter (proportional vacuum

- siphon) cycled at an average of 5.7 cycles per hour. Organism loading was calculated to be 0.03 g/L/day with a maximum loading at any point in time of 0.37 g/L.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

9 Dilution water was natural saltwater pumped from a shallow well. Th e saltwater was then filtered, carbon

- treated, and adjusted to a salinity of approximately 20 ppt with carbon

- treated aerated laboratory freshwater. This dilution water was re

- aerated prior to use.

A range

- finding test was conducted to determine the conc entration range for the definitive test. The nominal concentrations for the definitive test were: 15.6, 25.9, 43.2, 72.0 and 120 mg a.i./L. No solvent was utilized to solubilize the test material as Triazine is completely miscible in water.

Twenty sheep shead minnows were randomly distributed in the treatment and control chambers
of the flow

- through test system. Survival of the fish was monitored daily and any dead were removed. Any abnormalities in the behavior or physical appearance of the minnows wer e also noted. Test solutions were greatly aerated during the test.

Test water quality was monitored daily during the test. Water temperature was measured in the dilution water control container hourly during the test. Salinity was measured once daily. Dissolved oxygen concentrations and pH were measured daily in all test solutions with surviving
fish.

Water samples were collected from the controls and all five test solutions at test initiation, day 2, and termination to verify actual test concentratio ns. Mean measured concentrations were 11.8, 23.8, 38.9, 70.9, and 118 mg a.i./L.

RESULTS

Endpoint value(s): The 96

- hour LC 50 was > 118 mg a.i./L. The NOEC was 118 mg a.i./L.

Results remarks: Mortality of sheepshead minnows exposed for 96 hours to Tr iazine was zero at all concentrations tested. No mortality occurred in the dilution water control. The 96

- hour
LC 50 was greater than 118 mg a.i./L. The NOEC was 118 mg a.i./L, based on lack of mortality
and sublethal effects at this test concentration a nd all lower test concentrations.

CONCLUSIONS

The 96

- hour LC 50 for sheepshead minnows was greater than 118 mg a.i./L, based on a lack of mortality and sublethal effects at the highest concentration tested.

STUDY RELIABILITY

[1] Reliable without restrictions. This study was classified as “core” by U.S. EPA’s Office of Pesticide Programs.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

10 REFERENCE

Ward, G.S. 1994. “Acute Toxicity to the Sheepshead Minnow, Cyprinodon variegatus

, Under
Flow

- through Test Conditions”. Performing Laboratory: Toxiko n Environmental Sciences, Jupiter, FL. Submitted by the Triazine Joint Venture, c/o Buckman Laboratories International, Inc., Memphis, TN. U.S. EPA MRID No. 431431

- 02.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

11 Study 3: Acute toxicity test in bluegill (LeBlanc and Sousa, 1982a)

Title: Acute Toxicity of Triadine 10 to Bluegill (Lepomis macrochirus)

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 63.6% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 6.4% sodium omadine, CAS No. not specified; 30% unidentified

Remarks: Formulation, also referred to as Triadine 10

METHOD

Method/guideline followed: Not specified

Test type: Acute Toxicity for Freshwater Fish, Bluegill (Lepomis macrochirus)

GLP compliant?: Not specified

Year study was performed: 1982

Test species: Bluegill (Lepomis macrochirus)

Analytical monitoring: Not specified

Exposure duration: 96 hours

Concentrations tested: 36, 60, 100, 170, and 280 mg/L (not specified whether the concentrations were nominal or measured)

Test method/conditions remarks: Detailed methods for the exposure were not specified. The test procedure did not comply with the recommended EPA protocol of October 1982 (Part 158).
The LC 50 was estimated using a binomial test.

RESULTS

Endpoint value(s): The 96

- hour LC 50 value for bluegill was 77 mg/L.

Results remarks: No mortality was observed at 36 and 60 mg/L. Mortality was 100% at 100, 170, and 280 mg/L. The 96

- hour LC 50 value for bluegill was 77 mg/L and the confidence interval was 60 to 100 mg/L.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

12 CONCLUSIONS

This study indicates that the test substance is slightly toxic to bluegill with an LC 50 of 77 mg/L.

STUDY RELIABILITY

[2] Reliable with restrictions. Deviations from the EPA protocol of October 1982 (part 158) included: (1) a formulated product was used, which was a mixture of two active ingredients; (2) the number of fish per concentration was not specified; and (3) dissolv ed oxygen after 96 hours in the control and 36 mg/L concentrations was 3.7 and 1.7 ppm, respectively, which is below 40% saturation. This study was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provid e useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to describe the acute toxicity to fish.

REFERENCE

LeBlanc, G., and Sousa, J. 1982a. Acute Toxicity of Triadine 10 to Bluegill ( L epomis macrochirus ); Report # BW

- 82

- 2

- 1119. Performing Laboratory: EG&G Bionomics. Submitted by the Olin Corporation, New Haven, CT. U.S. EPA MRID No. 00105191.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

13 Study 4: Acute toxicity study in rainbow trout (Raasina, 1973)

Title: Four

- day Static Fish Toxicity Studies with Milidin X

- 2 Rainbow Trout and Bluegills

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; Purity: not specified.

Remarks: Also referred to as Grotan and Milidin X

- 2

METHOD

Method/guideline followed: Not specified

Test type: Acute toxicity test for Freshwater Fish, Rainbow Trout ( Oncorhynchus mykiss ),
static

GLP compliant?: No

Year study was performed: 1973

Test species: Juvenile rainbow trout ( O. mykiss ); length = 35

- 75 mm

Analytical monitoring: No

Exposure duration: 96 hours

Concentrations tested: Nominal: 0, 18, 32, 56, 78 and 100 mg/L

Test method/conditions remarks: Juvenile rainbow trout were observed for general health and suitability for a period not less than 14 days prior to experimental use in preliminary screening
studies. A 24

- hour acclimation period was conducted prior to the definitive test. Fish length ranged from 35 to 75 mm. This fish were fed either frozen brine shrimp or Purina Trout Chow #2 until 72 hours prior to test initiation. The water te mperature was held at 12oC for a minimum of 14 days prior to testing. The holding and dilution water consisted of reconstituted deionized water, supplemented with 30 mg/L calcium sulfate, 30 mg/L magnesium sulfate, 48 mg/L sodium bicarbonate, and 2 mg/L p otassium chloride. Stock solutions were prepared within one hour of dosing and were dispensed as a 10% (w/v) aqueous solution.

A range

- finding test was conducted to determine the concentration range for the definitive test. For the definitive test, nomi nal test concentrations were: 0 (control), 18, 32, 56, 78 and 100 mg/L. No solvent was utilized to solubilize the test material. Ten fish per test concentration were placed in each test vessel under static conditions. The test vessels were lined with

po lyethylene bags. There was one replicate per test concentration. The fish were not fed duringFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

14 treatment. The untreated control consisted of dilution water and was treated similarly to the dosed groups. A positive control was included, in which fish wer e exposed to toxaphene in a 0.1% (w/v) solution in acetone. Observations were made during the first 6 hours and at 24, 48, 72, and 96 hours. Dissolved oxygen and pH values were measured for the groups which experienced mortality and daily for the untreat ed control group. The Litchfield and Wilcoxon
tests were used to determine the LC 50

.

RESULTS

Endpoint value(s): The 96

- hr LC 50 for rainbow trout was 74 mg/L. The NOEC was 18 mg/L.

Results remarks: The untreated control had zero mortality. The mortality rates were 0, 0, 10, 50, and 100% at 18, 32, 56, 78, and 100 mg/L, respectively. Other toxic effects included dark discoloration and quiescence observed at all concentrations except 0 and 18 mg/L. Surfacing was observed at 78 and 100 mg/L. The measured pH range was 7.8 to 9.4. The control pH ranged from 7.1 to 7.3. The dissolved oxygen concentration ranged from 7.7 to 9.3 ppm (62 to 74%). The control dissolved oxygen ranged from 6.6 to 8.0 ppm ( 53 to 64%).

The study authors reported a 96

- hr LC 50 for rainbow trout of 74 mg/L, with a 95% confidence
interval of 61

- 89 mg/L, as well as a NOEC of 18 mg/L, based on the absence of mortality and
sublethal effects. An EPA OPP reviewer used EPA's TOXANA L program to verify the study author’s values. The LC 50 determined by TOXANAL was 74 mg/L, with a 95% confidence
interval of 64.2

- 83.4 mg/L. The NOEC was not available through the TOXANAL program.

CONCLUSIONS

The 96

- hr LC 50 for rainbow trout was 74 mg/L. The NOEC was 18 mg/L, based on the absence of mortality and sublethal effects.

STUDY RELIABILITY

[2] Reliable with restrictions. Deviations from the EPA protocol OPPTS Guideline 850.1075 included the following: (1) test chemical concentrations were not monitored and recorded throughout the experiment; (2) the length of the longest fish was > 2x the shortest fish; (3) fish were fed until 72 hours prior to test initiation rather than the recommended 48 hours; (4) pH and
dis solved oxygen (DO) were only measured daily for the control and if mortality occurred rather than daily for the control and all test groups; (5) some pH measurements (which ranged from 7.1 to 9.4) were outside of the acceptable range (guideline specifies 6 .0 to 8.0); (6) the following information was not provided: LC 50 and 95% confidence limits for 24, 48, and 72 hours, range

finding study data, purity and physicochemical characteristics of test material, temperature of water during test period, water hardn ess and salinity, methods and data from water sample analysis verifying concentration and impurities, pretest mortality and disease treatment, description of acclimation and test facilities, weight of fish, supplier of fish, whether fish were
used in other tests prior to this study, data on fish placement in test chamber and whether distributed randomly, fish loading rate, construction materials used for the test tanks and covers over tanks, calibration or aeration of test system and flow rate, photoperiod and light intensity,Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

15 method of stock preparation, test date and personnel, list of any protocol deviations occurring during test dates, quality assurance and GLP compliance statements, and concentration

- response and concentration

- mortality curves. This st udy was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to
describe the acute toxicity to fish.

REFERENCE

Raasina, G. 1973. Four

- Day Static Fish Toxicity Studies with Milidin X

- 2 in Rainbow Trout and Bluegills; Report ID# IBT No. 665

- 03509. Performing Laboratory: Industrial Bio

- test Laboratories, Inc. Submitted by the De Mille Chemical Corporation. U.S. EPA MRID No.
00073588.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

16 Study 5: Acute toxicity study in bluegill (Raasina, 1973)

Title: Four

- day Static Fish Toxicity Studies with Milidin X

- 2 Rainbow Trout and Bluegills

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; Purity: not specified.

Remarks: Also referred to as Grotan and Milidin X

- 2

METHOD

Method/guideline followed: Not specified

Test type: Acute toxicity test for Freshwater Fish, Bluegill ( Lepomis macrochirus ), static

GLP compliant?: No

Year study was performed: 1973

Test species: Juvenile bluegill ( L. macrochirus ); length = 35

- 75 mm

Analytical monitoring: No

Exposure duration: 96 hours

Concentrations tested: Nominal: 0, 18, 32, 56, 78 and 100 mg/L

Test method/conditions remarks: Juvenile bluegill were observed for general health and suitability for a period not less than 14 days prior to experimental use in preliminary screening
studies. A 24

- hour acclimation period was conducted prior to the definitive test. Fish length ranged from 35 to 75 mm. This fish were fed either frozen brine shrimp or Purina Trout Chow #2 until 72 hours prior to test initiation. The water temperature was held at 18oC for a minimum of 14 days prior to testing. The holding and dilution water consisted of reconstituted de ionized water, supplemented with 30 mg/L calcium sulfate, 30 mg/L magnesium sulfate, 48 mg/L sodium bicarbonate, and 2 mg/L potassium chloride. Stock solutions were prepared within one hour of dosing and were dispensed as a 10% (w/v) aqueous solution.

A range

- finding test was conducted to determine the concentration range for the definitive test. For the definitive test, the nominal test concentrations were: 0 (control), 18, 32, 56, 78 and 100 mg/L. No solvent was utilized to solubilize the test materia l. Ten fish per test concentration were placed in each test vessel under static conditions. The test vessels were lined with polyethylene bags. There was one replicate per test concentration. The fish were not fed during
treatment. The untreated contr ol consisted of dilution water and was treated similarly to theFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

17 dosed groups. A positive control was included, in which fish were exposed to toxaphene in a 0.1% (w/v) solution in acetone. Observations were made during the first 6 hours and at 24, 48, 72, and 96 hours. Dissolved oxygen and pH values were measured for the groups which experienced mortality and daily for the untreated control group. The Litchfield and Wilcoxon
tests were used to determine the LC 50

.

RESULTS

Endpoint value(s): The 96

- hr L C 50 for bluegill was 40 mg/L. The NOEC was 18 mg/L.

Results remarks: The untreated control had zero mortality. The mortality rates were 0, 20, 90, 100, and 100% at 18, 32, 56, 78, and 100 mg/L, respectively. Other toxic effects included dark discoloration and quiescence observed at all concentrations except 0 and 18 mg/L. Surfacing was observed in bluegill at 56, 78, and 100 mg/L. The measured pH range was 8.7 to 9.3. The control pH ranged from 6.9 to 7.1. The dissolved oxygen concentration ranged from 6.5 to 8.5 ppm (52 to 68%). The control dissolved oxygen ranged fr om 7.4 to 7.9 ppm (59 to 63%).

The study authors reported a 96

- hr LC 50 for bluegill of 40 mg/L, with a 95% confidence interval
of 33

- 49 mg/L, as well as a NOEC of 18 mg/L, based on the absence of mortality and sublethal effects. An EPA OPP reviewer used EPA's TOXANAL program to verify the study author’s
values. The LC 50 determined by TOXA NAL was 40 mg/L, with a 95% confidence interval of
32.2

- 48.3 mg/L. The NOEC was not available through the TOXANAL program.

CONCLUSIONS

The 96

- hr LC 50 for bluegill was 40 mg/L. The NOEC was 18 mg/L, based on the absence of mortality and sublethal effect s.

STUDY RELIABILITY

[2] Reliable with restrictions. Deviations from OPPTS Guideline 850.1075 included the following: (1) test chemical concentrations were not monitored and recorded throughout the experiment; (2) the length of the longest fish was > 2x the shortest fish; (3) fish were fed until 72 hours prior to test initiation rather than the recommended 48 hours; (4) pH and dissolved oxygen (DO) were only measured daily for the control and if mortality occurred rather than daily for the
control and al l test groups; (5) some DO measurements (which ranged from 6.5 to 8.5 ppm [52 to 68%]) were outside of the acceptable range for a static test (guideline specifies > 60%); (6) some pH measurements (which ranged from 6.9 to 9.3) were outside of the acceptabl e range (guideline specifies 6.0 to 8.0); (7) the following information was not provided: LC 50 and 95% confidence limits for 24, 48, and 72 hours, range

- finding study data, purity and physicochemical characteristics of test material, temperature of water d uring test period, water hardness and salinity, methods and data from water sample analysis verifying concentration and impurities, pretest mortality and disease treatment, description of acclimation and test facilities, weight of fish, supplier of fish, w hether fish were used in other tests prior to this study, data on fish placement in test chamber and whether distributed randomly, fish loading rate, construction materials used for the test tanks and covers over tanks, calibration or aeration of test syst em andFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

18 flow rate, photoperiod and light intensity, method of stock preparation, test date and personnel, list of any protocol deviations occurring during test dates, quality assurance and GLP compliance statements, and concentration

- response and concentrat ion

- mortality curves. This study was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evi dence approach to describe the acute toxicity to fish.

REFERENCE

Raasina, G. 1973. Four

- Day Static Fish Toxicity Studies with Milidin X

- 2 in Rainbow Trout and Bluegills; Report ID# IBT No. 665

- 03509. Performing Laboratory: Industrial Bio

- test Laborator ies, Inc. Submitted by the DeMille Chemical Corporation. U.S. EPA MRID No.
00073588.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

19 Study 6: Acute toxicity test in rainbow trout (Sousa and LeBlanc, 1982a)

Title: Acute Toxicity of Triadine 10 to Rainbow Trout ( Salmo gairdneri )

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4, Purity: 63.6

- 65.9%; Impurity: ~ 6.4% sodium omadine, CAS No. not specified; ≥ 30% unidentified

Remarks: Also referred to as Grotan and Triadine 10; Industrial Microbiostat, Lot No. OD

9211

METHOD

Method/guideline followed: Not specified

Test type: Acute toxicity test in for Freshwater Fish, Rainbow Trout ( Oncorhynchus mykiss ),
static

GLP compliant?: No

Year study was performed: 1982

Test species: Juvenile rainbow trout, obtained from a commercial fish supplier in M ontana (Bionomics lot no. 81A33); average wet weight: 0.63 g; average length: 43 mm

Analytical monitoring: No

Exposure duration: 96 hours

Concentrations tested: Nominal: 7.8, 13, 22, 36, and 60 mg/L

Test method/conditions remarks: Juvenile rainbow trout

, obtained from a commercial fish supplier in Montana (Bionomics lot no. 81A33), were allowed to acclimate for 14 days. The fish were held in well water that flowed through the holding tank at a rate of 13

- 15 tank volume replacements/day. The total hardness of the holding water was 30 mg CaCO 3 /L, the alkalinity
was 24

- 30 mg CaCO 3 /L, the specific conductance was 100 μhos/cm, the pH ranged from 6.7

- 6.9, the temperature was 11

- 12 oC, the photoperiod was 16 hours light/8 hours dark, and the dissolved oxygen ranged from 83

- 94% of saturation. While being held, the fish were fed dry pellet food daily, ad libitum . Food was withheld for 48 hours prior to testing. The pretest mortality, observed for 48 hours prior to testing, was 0.2%.

The dilution water consisted of soft water reconstituted from deionized water, using EPA recommended proc edures, and had a hardness of 42 mg CaCO 3 /L and specific conductance of 140 μhos/cm. The stock solution of Triadine 10 (15 mg/L) was prepared by adding distilledFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

20 water to 7.5 grams of Triadine 10 in a 500

- mL volumetric flask, until an appropriate volume h ad
been reached. The test vessels consisted of 19.6

- L glass jars with 15 L of test solution. No evidence of a range

- finding study was recorded.

Ten juvenile rainbow trout per replicate were distributed randomly to each test jar within 10 minutes after the preparation of the test solution, and were exposed to nominal concentrations of 7.8, 13, 22, 36, or 60 mg/L under static conditions. The negative control jar contained th e same dilution water as in the exposure jars. Three replicates were used for each concentration. The wet weight of the fish was ~0.63 g (ranging from 0.41 to 0.94 g), and the length was ~43 mm (ranging from 39 to 48 mm). All test temperatures were main tained at 12 ± 1 oC upon the addition of rainbow trout, were not aerated, and had a photoperiod of 16 hours light/8 hours dark. Biological observations were made every 24 hours. The temperature was recorded once for each exposure time during the definiti ve test. The pH and dissolved oxygen concentrations were measured at 0, 24, 48, and 96 hours in the control, high, middle and low test concentrations. The
dose

- related mortality data from the definitive toxicity test was used to estimate the 24

- , 48

- , 72

- , and 96

- hour median lethal concentrations and 95% confidence intervals. Toxanol was used to perform the statistical analysis, using the moving average angle method.

It should be noted that this study was reviewed in two OPP documents, and there are som e inconsistencies between these two reviews (authored by C. E. Laird [1983] and W. Erickson [2008]). In one OPP review (by W. Erickson [2008]), the purity of the test substance is reported as 65.9%, while in the second review (by C. E. Laird [1983]), the purity of the test substance is stated as 63.6%, with sodium omadine as a component (6.4%). Additionally, it should be noted that only about 70% of this tested compound is accounted for by sodium omadine and Triadine 10 in this study, leaving about 30% of the compound as “unknown substance.”

RESULTS

Endpoint value(s): The 96

- hr LC 50 for rainbow trout was 42 mg/L. The LOEC was 7.8 mg/L, based on sublethal effects, and the NOEC was < 7.8 mg/L.

Results remarks: The pH and dissolved oxygen concentrations and ranged from 6.8 to 9.1 and 6.9 to 10.6 mg/L, respectively. Mortality occurred at nominal concentrations of 36 and 60 mg/L at rates of 40 and 80%, respectively. No mortality was observed at concentrations ≤ 2 2 mg/L. Sublethal effects were observed at all treatment concentrations. Darkened pigment was noted at all concentrations and at all exposure times except 24 hours. Fish were respiring rapidly over all
concentrations after 96

- h exposure, and at concentr ations greater than 22 mg/L after 72 and 48

- h

exposures.

Using a moving average statistical method, the 96

- hr LC 50 for rainbow trout was determined to be 42 mg/L, with a 95% confidence interval of 34

- 53 mg/L. The NOEC was < 7.8 mg/L, based
on sublethal effects observed at the lowest concentration tested.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

21 CONCLUSIONS

The 96

- hr LC 50 for rainbow trout was 42 mg/L. The NOEC was < 7.8 mg/L, based on sublethal effects including rapid respiration and dark coloration.

STUDY RELIABILITY

[2] Reliable with r estrictions. Deviations from OPPTS Guideline 850.1075 included the following: (1) the test substance was a formulated product, which was a mixture of more than one ingredient, and test chemical concentrations were not monitored and recorded throughout the experiment (guideline requires measurement at 0, 48, and 96 hours); (2) holding water and test
water dilution came from two different sources and rainbow trout were not held in the test water dilution for a minimum of 7 days during the acclimation period; (3) no evidence of a range

finding test was provided as a basis for definitive test concentrations; (4) the number of replicates for each concentration was not explicitly stated (three replicates assumed based on n = 30); (5) some pH measurements (range = 6.8

- 9.1) were outside the recommended range for freshwater species (6.0

- 8.0); and (6) the following information was not provided: chemical analysis of dilution water, pretest mortality for the entire acclimation period, health of fish prior
to test initia tion, use and type of cover for test vessels, dissolved oxygen data at 72 hours, hourly temperatures in one replicate throughout the study, analysis of the stability of the test chemical, mortality at 6 hours, a graph of the concentration

- mortality curve, and quality assurance and GLP compliance statements. This study was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to describe the acute toxicity to fish.

REFERENCE

Sousa, J.V., and LeBlanc, G.A. 1982a. Acute Toxicity of Triadine 10 to Rainbow Trout ( Salmo gairdneri ); Laboratory Report BW

- 82

- 2

- 1117. Performing Laboratory: EG&G, Bionomics, Aquatic Toxicology Laboratory, Wareham, MA. Submitted by the Olin Corporation, New Haven, CT. U.S. EPA MRID Nos. 247712 and 00105190.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

22 Study 7: Acute toxicity study in rainbow trout (Sousa and LeBlanc, 1982b)

Title: Acute Toxicity of Milidin X

- 2 to Rainbow Trout ( Salmo gairdneri )

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol , CAS No. 4719

- 04

- 4; Purity: not specified.

Remarks: Also referred to as Grotan and Milidin X

- 2.

METHOD

Method/guideline followed: Not specified

Test type: Acute Toxicity Test for Freshwater Fish, Rainbow Trout ( Oncorhynchus mykiss ),
static

GLP compliant?: No

Year study was performed: 1982

Test species: Juvenile r ainbow trout; average wet weight: 0.28 g; average length: 35 mm

Analytical monitoring: No

Exposure duration: 96 hours

Concentrations tested: Nominal: 0 (control), 17, 28, 46, 48, and 100 mg/L

Test method/conditions remarks: Juvenile rainbow trout were allowed to acclimate for 14 days prior to experimental use. The holding water was well water with a flow

- through rate of 13 tank volume replacements/day. The total hardness of the holding water was 30

- 34 mg CaCO 3 /L, alkalinity was 26

- 29 mg CaCO 3 /L, pH was 7.1

- 7.2, temperature was 11

- 12 oC, and dissolved oxygen ranged from 98

- 100% of saturation at 12 oC. The fish were fed dry pellets of food daily,
ad libitum . The pretest mortality rate, observed du ring the 48

- hour period prior to testing, was
0.3%.

The dilution water consisted of soft water reconstituted from deionized water, using EPA recommended procedures. The dilution water had a hardness of 46 mg CaCO 3 /L and specific conductance of 140 μhos/ cm, measured at the start of the definitive study. The stock solution of
Milidin X

- 2 (15 mg/L) was prepared by adding distilled water to 7.5 grams of Milidin X

- 2 in a
500

- mL volumetric flask. Test chambers consisted of 19.6

- L glass jars, each containing 15 L of test solution. No evidence of a range

- finding study was provided.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

23 Ten juvenile rainbow trout were distributed randomly to each test chamber within 30 minutes after the preparation of the test solutions, and were exposed to nominal concentrations of 17 , 28, 46, 48, or 110 mg/L under static conditions. The negative control contained the same dilution water as in the treatment chambers. Three replicates were used per treatment level. Biological observations were made every 24 hours. The fish were 0.28 (0.18

- 0.42) g wet weight, and 35 (30

- 38) mm in length. Food was withheld for 48 hours before the definitive test began. All test
solutions were maintained at 12 ± 1 oC and were not aerated . The pH and dissolved oxygen
concentrations were measured at 0, 24, 48, and 96 hours in the control, high, middle and low test
concentrations.

The dose related mortality data from the definitive toxicity test was used to estimate the 24

- , 48

- , 72

- , and 96

- hour median lethal concentrations and 95% confidence int ervals. A computer program (Stephan, C. 1978. U.S. EPA, Environmental Research Laboratory, Duluth, MN) was used to perform the statistical analysis. An EPA OPP reviewer used EPA's Toxanol program to verify the LC 50 values using the moving average angle a nalysis and the probit method.

RESULTS

Endpoint value(s): The 96

- hr LC 50 for rainbow trout was 71 mg /L. The LOEC was 28 mg/L, based on sublethal effects, and the NOEC was 17 mg/L.

Results remarks: The range of test temperatures was 11

- 12 oC. The pH ranged from 7.0 to 9.4 and dissolved oxygen from 8.6 to 11.6 mg/L (76

- 100% saturation). The measured pH values exceeded the acceptable range for freshwater fish testing.

The mortality rates at nominal concentrations of 68 mg/L and 110 mg/L were 20 an d 100%, respectively. No mortality was observed at concentrations ≤ 46 mg/L. Other effects observed included darkened pigmentation in the latter half of the study in the 28 mg/L and the 46 mg/L dose groups, as well as all timeframes of the 68 mg/L test g roup and at the 24

- hour mark in the 110 mg/L test group. Fish were found swimming at the surface of the test solution during the
24

- hour mark for the 110 mg/L test group, as well as at the 48

- , 72

- , and 96

- hour test marks for the 69 mg/L test group. Fish were observed respiring rapidly at the 96

- hour mark for the 46 mg/L test group.

The study authors reported a 96

- hr LC 50 of 71 mg/L, with a 95% confidence interval of 46

- 110 mg/L. The 96

- hr LC 50 obtained using Toxanol was 79 mg/L, with a 95% confidence interval of
46

- 110 mg/L. The NOEC was 17 mg/L, based upon darkened pigmentation at 28 mg/L.

CONCLUSIONS

The 96

- hr LC 50 for rainbow trout was 71 mg/L. The LOEC was 28 mg/L, based on sublethal effects, and the NOEC was 17 mg/L.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

24 STUDY RELIABILITY

[2] Reliable with restrictions. Deviations from OPPTS Guideline 850.1075 included the following: (1) purity and physicochemical characteristics of the test material were not provided; (2) test chemical concentrations were not monitored through the experim ent (guidelines require measurements at 0, 48, and 96 hours); (3) holding water and test water dilution came from two different sources and fish were not held in the test water dilution for a minimum of 7 days during the acclimation period; (4) the number of replicates for each concentration was not explicitly stated (assumed three replicates based on n = 30); (5) the pH of 7.0 to 9.4 did not always fall within the recommended range for freshwater species of 6.0

- 8.0 ; and (6) the following
information was no t provided: chemical analysis of dilution water, pretest mortality rates for the
14

- day acclimation period, photoperiod, background colors, light intensities, fish supplier, fish source population, breeding history, whether fish had been previously tested, biomass loading rate, use and type of cover for test chambers, dissolved oxygen concentration at 72 hours, data from a range

- finding test, hourly temperatures in one replicate throughout the study, analysis of the stability of the test chemical, mortality at 6 hours, a graph of the concentration

- mortality curve, and quality assurance and GLP compliance statements. This study was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to describe the acute toxicity to fish.

REFERENCE

Sousa, J.V. and LeBlanc, G.A. 1982b. Acute Toxicity of Milidin X

- 2 to Rainbow Trout ( Salmo gairdne ri ); Laboratory Report BW

- 82

- 4

- 1145. Performing Laboratory: EG&G, Bionomics Aquatic Toxicology Laboratory, Wareham, MA. U.S. EPA MRID No. 248883.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

25 Study 8: Acute toxicity study in bluegill (Sousa and LeBlanc, 1982c)

Title: Acute Toxicity of Milidin X

- 2 to Bluegill (Lepomis macrochirus)

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol , CAS No. 4719

- 04

- 4; Purity: not specified.

Remarks: Also referred to as Grotan and Milidin X

- 2.

METHOD

Method/guideline followed: Not specified

Test type: Acute Toxicity Test for Freshwater Fish, Bluegill ( L. macrochirus ), static

GLP compliant?: No

Year study was performed: 1982

Test species: Juvenile b luegill, obtained from a commercial fish supplier in Connecticut (Bionomics Lot No. 81A27), average wet weight = 0.34 g; average length = 34 mm

Analytical monitoring: No

Exposure duration: 96 hours

Concentrations tested: Nominal: 0 (control), 13, 22, 36, 60, and 100 mg/L

Test method/conditions remarks: Juvenile bluegill were allowed to acclimate for 14 days prior to experimental use. The h olding water was well water that flowed through the tank at a rate of
9

- 10 tank volume replacements/day. The total hardness of the holding water was 30

- 34 mg
CaCO 3 /L, the alkalinity was 26

- 29 mg CaCO 3 /L, the pH ranged from 6.8

- 7.0, the temperature
was 20

- 21 oC, the specific conductance was 105

- 120 μmhos/cm, the photoperiod was16 hours light/8 hours dark, and the dissolved oxygen was100% of saturation at 20 oC. The fish were fed dry pellet food daily, ad libitum . The pretest mortality rate, observed 48 hours prior to testing,
was 1.0%.

The dilution water consisted of soft water reconstituted from deionized water, using EPA recommended procedures. The stock solution of Milidin X

- 2 (15 mg/L) was prepa red by adding distilled water to 7.5 grams of Milidin X

- 2 in a 500

- mL volumetric flask. No evidence of a

range

- finding study was provided.

Ten juvenile bluegill per replicate were distributed randomly into 19.6

- L glass test jars containing 15 L of test s olution within 30 minutes after the preparation of the test solution. ThisFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

26 fish were exposed to nominal concentrations of 13 , 22, 36, 60, or 100 mg/L under static conditions. The negative control contained the same dilution water as in the exposure chamb ers. Three replicates were used per concentration. Biological observations were made every 24 hours. The fish were 0.34 (0.20

- 0.52) g wet weight, and 34 (30

- 38) mm in length. Food was withheld for 48 hours before the definitive test began. All test te mperature solutions were
maintained at 21

- 22 oC and were not aerated . The pH and dissolved oxygen concentrations were measured at 0, 24, 48, and 96 hours in the control, high, middle and low test concentrations.

The dose related mortality data from the definitive toxicity test was used to estimate the 24

- , 48

- , 72

- , and 96

- hour median lethal concentrations and 95% confidence intervals. A computer program (Stephan, C. 1978. U.S. EPA, Environmental Research Laboratory, Duluth, MN) was used to perform the statistical analysis. An EPA OPP reviewer used EPA's Toxanol program to verify the LC 50 values using the moving average angle analysis and the probit method.

RESULTS

Endpoint value(s): The 96

- hr LC 50 for bluegill was 39 mg/L. The LOEC was 13 mg/L, based on sublethal effects observed at the lowest concentration tested, and the NOEC was < 13 mg/L.

Results remarks: The pH ranged from 6.8 to 9.4 and the dissolved oxygen concentration ranged from 1.2

- 11.4 mg/L (14

- 100% saturation). Some of the measure d pH values exceeded the recommended range for freshwater fish testing. The total hardness, measured at the beginning of the test, was 46 mg CaCO 3 /L. The alkalinity was 31 mg CaCO 3 /L, specific conductance was 140 μmhos/cm, and the photoperiod was 16 hour s light/8 hours dark

.

Mortality rates observed after 96 hours at nominal concentrations of 22, 36, 60, and 100 mg/L were 10, 30, 90, and 100%, respectively. Sublethal effects were observed in all test groups, except the high

- dose group where the effect s were 100% mortality. At the 72

- and 96

- hour marks for the 13 and 22 mg/L dose groups, cloudy test solutions, lethargy, rapid respiration, erratic swimming, and darkened pigmentation were observed. Cloudiness and rapid respiration
were also observed at the 96

- hour mark in the 36 mg/L dose group. Six fish were lethargic at 24 hours in the 60 mg/L dose group, with two still lethargic at the 48

- and 72

- hour marks. Lethargy and erratic swimming were also seen at 96 hours in the 60 mg/L dose group.

The s tudy authors reported a 96

- hr LC 50 for bluegill of 39 mg/L, with a 95% confidence interval (C.I.) of 31 to 50 mg/L. The NOEC was < 13 mg/L, the lowest concentration tested, based on rapid respiration and darkened pigmentation at 13 mg/L. Using Toxanol, t he 96

- hr LC 50 was 39 mg/L (95% C.I. = 31

- 50 mg/L) using the moving average method and the 96

- hr LC 50 was 40 mg/L (95% C.I. = 32

- 50 mg/L) using the probit method.

CONCLUSIONS

The 96

- hr LC 50 for bluegill was 39 mg/L. The NOEC was < 13 mg/L, based on subl ethal effects
at the lowest dose tested.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

27 STUDY RELIABILITY

[2] Reliable with restrictions. Deviations from OPPTS Guideline 850.1075 included the following: (1) purity and physiochemical characteristics of the test material were not provided; (2) test chemical concentrations were not monitored and recorded through the experiment (guidelines require measurements at 0, 48, and 96 hours); (3) holding water and test dilution
water came from two different sources and fish were not held in the dilution water for a minimum of 7 days during the acclimation period; (4) the temperature in the holding tank during the 48 hours prior to testing was 20 oC, whereas protocol suggests 22 ± 1 oC; (5) measured dissolved oxygen concentrations (14

- 100% saturation) were not maintained at > 60% throughout the whole test; (6) some pH measu rements (range = 6.8 to 9.4) were outside the recommended range (6.0

- 8.0) for freshwater species; and (6) the following information was not provided: physical condition and signs of disease in the fish, chemical analysis of dilution water, pretest
mortalit y rates for the entire 14

- day acclimation period; use and type of cover for test vessels, dissolved oxygen concentration at 72 hours, range

- finding test data, explicit statement of the number of replicates for each concentration (assumed three replicates b ased on n = 30), hourly temperatures in one replicate throughout the study, analysis of the stability of the test chemical, mortality at 6 hours, graph of the concentration

- mortality curve, and quality assurance and GLP compliance statements. This study w as classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to describe the

acut e toxicity to fish.

REFERENCE

Sousa, J.V., and LeBlanc, G.A. 1982c. Acute Toxicity of Milidin X

- 2 to Bluegill ( Lepomis macrochirus ); Laboratory Report BW

- 82

- 4

- 1144. Performing Laboratory: EG&G, Bionomics Aquatic Toxicology Laboratory, Wareham, MA. U.S. EPA MRID No. 248883.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

28 Study 9: Acute toxicity study in channel catfish (LeBlanc and Sousa, 1982b)

Title: Acute Toxicity of Triadine 10 to Channel Catfish ( Ictalurus punctatus )

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 63.6% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol , CAS No. 4719

- 04

- 4; 6.4% sodium omadine, CAS No. not specified; 30% unidentified

Remarks: Formulation, als o referred to as Triadine 10

METHOD

Method/guideline followed: Not specified

Test type: Acute Toxicity Test for Freshwater Fish, Channel Catfish ( Ictalurus punctatus ) (static or flow

- through not specified)

GLP compliant?: No

Year study was performed: 1982

Test species: Channel catfish ( Ictalurus punctatus )

Analytical monitoring: Not specified

Exposure duration: 96 hours

Concentrations tested: 6, 10, 17, 28, and 46 mg/L (nominal or measured not specified)

Test method/conditions remarks: Channel catfish (10/dose) were exposed to concentrations of 6, 10, 17, 28, or 46 mg/L. Test procedures did not comply with the recommended EPA protocol of October 1982 (Part 158).

An EPA OPP reviewer used a binomial probability test to estimate the LC 50 value.

RESULTS

Endpoint value(s): The 96

- hr LC 50 for channel catfish was 36 mg/L.

Results remarks: The mortality rate was 0, 10, 0, 0, and 100% at test substance concentrations
of 6, 10, 17, 28, and 46 mg/L , respectively. Using th e binomial probability method, the LC 50 was 36 mg/L, with a 95% confidence interval of 28 to 46 mg/L.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

29 CONCLUSIONS

The 96

- hr LC 50 for channel catfish was 36 mg/L, estimated by binomial probability. The test substance was found to be slightly toxic to channel catfish.

STUDY RELIABILITY

[2] Reliable with restrictions. A formulated product was used instead of a technical grade chemical; the test substance was a mixture of two active ingredients. This study was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide useful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to describe the acute toxicity to fish.

REFERENCE

LeBlanc, G., Sousa, J. 1982b. Acute Toxicity of Triadine 10 to Channel Catfish ( Ictalurus
punctatus ); Report # BW

- 82

- 2

- 1120. Performing Laborotory: EG&G Bionomics. Submitted by the Olin Corporation, New Haven, CT. U.S. EPA MRID No. 00105189.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

30 D

- 2. Acute Toxicity to Aquatic Invertebrates

Summary of endpoint: Adequate

Study 1: Acute toxicity study in Daphnia magna (Davis, 1994)

Title: Triazine: Acute Toxicity to the Water Flea, Daphnia magna , Under Flow

- through Test
Conditions

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 83.8% Triazine, CAS No. 4719

- 04

- 4; 16.2% unidentified

Remarks: Also referred to as Triazine and Shaughnessey No. 083301; Technical grade; Lot No. 0952309; clear yellow viscous liquid.

METHOD

Method/guideline followed: OPP 72

- 2(A)

Test type: Freshwater Invertebrate Flow

- Through Acute Toxicity Test

GLP compliant?: Not specified

Year study was performed: 1994

Test species: Water fleas, D. magna , (<24 hours old) taken from in

- house cultures.

Analytical monitoring: Yes

Exposure duration: 48 hours

Concentrations tested: Nominal: 0 (control), 7.78, 13.0, 21.6, 36.0, 60.0 and 100 mg a.i./L; mean measured: 0 (control), 7.49, 13.2, 19.7, 34.5, 59.0, and 95.2 mg a.i./L

Test method/conditions remarks: For the definitive test, the nominal test concentrations were 100, 60.0, 3 6.0, 21.6, 13.0, and 7.78 mg a.i./L and a dilution water control. The definitive test
was conducted under flow

- through conditions in a modified proportional diluter system constructed of glass, silicone adhesive, and silicone tubing. A total volume of 53 .9 μL of test substance was pumped into the chemical mixing chamber during each diluter cycle, providing a high nominal test concentration of 100 mg a.i./L. The test solution was proportionally diluted to provide the 5 lower test concentrations. A dilutio n water control was also maintained. The test dilution water was a moderately hard fresh water, with a mean hardness of 113 mg/L as CaCO 3 , mean alkalinity of 32 mg/L, and a mean specific conductivity of 658 μmhos/cm.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

31 A test solution of ~ 220 mL was del ivered to each test chamber during every cycle: the total volume was split in halves via a splitter box. Test tanks were 11.3

- L glass tanks positioned to provide a maximum depth of 6 cm. Retention chambers were used to prevent neonate floating.
Each tes t container maintained a 450

- mL volume of test solution; the diluter cycled at an average rate of 2.9 cycles/hour providing ~ 17 volume additions every 24 hours.

Ten daphnids were impartially added to each chamber, with two chambers per concentration. All test containers were randomly positioned in a single water bath maintained at a temperature of 20 ± l° C. Fluorescent lighting provided a photoperiod of 16 hour s light/8 hours dark, with a
15

- minute transition period. The light intensity ranged between 308 and 375 lux.

Survival of daphnids was monitored daily and any dead removed. Abnormalities were also noted. Daphnids were not fed during the test. Test sol utions remained clear throughout the study.

Test water quality was monitored daily. Water samples were collected from the controls and all six test concentrations at initiation, day 1, and termination to verify concentrations. Samples were analyzed usin g HPLC.

The median effective concentrations (EC 50 ) and associated 95% confidence intervals (C.I.) were calculated using a computer program (moving average angle, probit, logit, and nonlinear interpolation).

RESULTS

Endpoint value(s): The 48 hour EC 50 value for D. magna was 26.1 mg a.i./L. The NOEC was 7.49 mg a.i./L based on mortality at the 13.2 mg a.i./L test concentration.

Results remarks: The diluter functioned properly throughout the test. The mean measured concentrations ranged from 7.49 to 95.2 mg a.i./L and from 91 to 102% of nominal. The mean measured concentrations were 7.49, 13.2, 19.7, 34.5, 59.0, and 95.2 mg a.i./L.

Mortality wa s 0, 5, 0, 100, 100, and 100% at mean measured concentrations of 7.49, 13.2, 19.7, 34.5, 59.0, and 95.2 mg a.i./L, respectively. The slope of the concentration response curve could not be determined using the binomial probabi1ity method. The study author determined the 48

- hour EC 50 as 26.1 mg a.i./L, with 95% confidence limits of 19.7 to 34.5 mg a.i./L, and a NOEC of 19.7 mg a.i./L.

An EPA OPP reviewer used EPA's Toxanal program to determine the 48

- hour EC 50 value as 26.1 mg a.i./ L (95% C.I. = 19.7

- 34.5 mg a.i./L). The NOEC was estimated to be 7.49 mg a.i./L, based on mortality at the 13.2 mg a.i./L concentration. This NOEC value is more conservative than the value reported by the study author, which was 19.7 mg a.i./L.

Initia l alkalinity, hardness, and conductivity of the dilution water as measured in the control were 32 mg/L, 130 mg/L, and 828 μmhos/cm, respectively. At test termination, they were 32 mg/L,Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

32 96 mg/L, and 488 μmhos/cm, respectively. During the test, the dissol ved oxygen remained ≥ 7.8 mg/L (≥ 88% saturation). The pH was affected by the presence of triazine, with pH increasing with triazine concentration. The pH ranged from 7.7 to 7.8 in the control and from 8.5 to 9.6 in
all test concentrations.

CONCLUSIONS

The 48 hour EC 50 for D. magna was 26.1 mg a.i./L. The NOEC was 7.49 mg a.i./L based on mortality at the 13.2 mg a.i./L test concentration.

STUDY RELIABILITY

[1] Reliable without restrictions. The study was scientifically sound and generally in accordance with SEP and ASTM guidelines. This study was classified as “core” by U.S. EPA’s Office of Pesticide Programs.

REFERENCE

Davis, J. W. 1994. Triazine: Acute toxicity to the water flea, Daphnia magna , under flow

- through test conditions. Project No. J9306004d. Performing Laboratory: Toxikon Environmental Sciences. Submitted by Triazine Joint Venture. U.S. EPA MRID No. 431754

- 01.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

33 Study 2: Acute toxicity study i n Daphnia magna (LeBlanc and Surprenant, 1982)

Title: Acute Toxicity of Triadine 10 to the Water Flea ( Daphnia magna )

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 63.6% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol , CAS No. 4719

- 04

- 4; 6.4% sodium omadine, CAS No. not specified; 30% unidentified

Remarks: Formulation, also referred to as Triadine 10

METHOD

Method/guideline followed: EPA October 1982, Part 158

Test type: Freshwater Invertebrate Acute Toxicity Test (static or flow

- through not specified)

GLP compliant?: Not specified

Year study was performed: 1982

Test species: Water fleas, D. magna

Analytical monitoring: Not specified

Exposure duration: 48 hours

Concentrations tested: 0.18, 0.3, 0.5, 0.8, 1.3, 2.2, 3.6, 6 and 10 mg/L (nominal or measured not specified)

Test method/conditions remarks: The test procedure complied with the recommended EPA protocol of October 1982 (Part 158) except that a formulat ed product was used instead of a technical grade chemical and the test substance was a mixture of two active ingredients.

Fifteen organisms were used per test concentration ( 0.18, 0.3, 0.5, 0.8, 1.3, 2.2, 3.6, 6, and 10 mg/L)

.

A computer program (Stephan, C. 1978. U.S. EPA, Environmental Research Laboratory, Duluth, MN) was used to perform the statistical analysis. An EPA OPP reviewer used EPA's Toxanol program to verify the EC 50 value using the moving average angle analysis and the probit method.

RESULTS

Endpoint value(s): The 48

- hour EC 50 value for Daphnia magna was 5.2mg/L.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

34 Results remarks: Mortality observed at concentrations of 0.18, 0.3, 0.5, 0.8, 1.3, 2.2, 3.6, 6, and 10 mg/L was 0%, 0%, 0%, 13.3%, 26.7%, 20%, 53.3%, 33.3% and 73.3%, respectively.

The study authors reported a 48

- hour EC 50 of 5.2 mg/L. Using Toxanol, the 48

- hour EC 50 , estimated by the moving average angle method was 5.4 mg/L, with a 95% confidence interval of
3.6

- 10.79.4 mg/L. Using the probit method, the 48

- h our EC 50 was 5.2 mg/L, with a 95%
confidence interval of 3.5

- 9.5 mg/L.

CONCLUSIONS

The 48

- hour EC 50 value for D. magna was 5.2 mg/L.

STUDY RELIABILITY

[2] Reliable with restrictions. A formulated product was used instead of a technical grade chemical; the test substance was a mixture of two active ingredients. This study was classified as “supplemental” by U.S. EPA’s Office of Pesticide Programs. The study is considered to provide us eful information, in support of core or key studies, and the results may be used as part of a weight

- of

- evidence approach to describe the acute toxicity to daphnids.

REFERENCE

LeBlanc, G., and Surprenant, D. 1982. Acute Toxicity of Triadine 10 to the Water Flea ( Daphnia

magna ); Report # BW

- 82

- 2

- 1122. Performing Laboratory: EG&G Bionomics. Submitted by the Olin Corporation, New Haven, CT. U.S. EPA MRID No. 00105192.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

35 D

- 3 . Toxicity to Aquatic Plants

Summary of endpoint: Adequate

Study 1: Toxicity to Pseudokirchneriella subcapitata ( Vryenhoef and Mullee, 2012 )

Title: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- T riethanol (C AS No. 4719

- 04

- 4 ): Algal Inhib i tion Test

This study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- triazine

- 1,3,5(2H,4H,6H)

- triethanol , CAS RN 4719

- 04

- 4

Remarks: Physical state: yellow slightly viscous liquid ; Composition: 1 ,3,5

- Triazine

1,3,5(2H,4H,6H)

- T riethanol (77.5%) and w ater (22.5%) ; Supplier: Q 2 Technologies; Batch #
3951

- 91

METHOD

Method/guideline followed: OECD TG 201 (2006); OPPTS 850.5400 (1996); ASTM E1218

- 04 (2004)

Test type: Static t oxicity test to freshwater algae

GLP compliant?: Yes

Year study was performed: 201 2

Test species: Freshwater green algae ( Pseudokirchneriella subcapitata strain CCAP 278/4

, formerly Selenastrum capricornutum ) ; culture supplied by the Culture Collection of Algae and Protozoa ( CCAP )

, SAMS Research Services Ltd, Scottish Marine Institute, Oban, Argyll,
Scotlan d

.

Analytical monitoring: Yes (degradation products only)

Exposure duration: 96 hours

Concentrations tested: Range

- finding test (nominal): 0, 0.10, 1.0, 10, 100, and 1000 mg active ingredient ( ai ) /L; mean measured concentrations were not provided. Definitive test (n ominal ) : 1.0, 3.2, 10, 32

, and 100 mg ai /L ; mean measured concentrations were not provided.

Test method/conditions remarks : After a range

- finding test at nominal concentrations ranging from 0.1 to 1000 mg active ingredient (ai)/L , a definitive growth inhibition test was conducted.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

36 T he test substance was dissolved directly in culture medium at nominal concentrations of 0, 1.0, 3.2, 10, 32, and 100 mg ai/L. The culture medium was prepared according to ASTM E 1218

- 04 ε1 using reverse osmosis purified deionised water as dilution water. Additional sodium bicarbonate (500 mg/L) was added to culture medium prior to the definitive test “to provide a sufficient supply of CO 2 and to counteract the increase in pH due to algal growth in an enclosed system

. ” [ Vryenhoef and Mullee 2012, p. 8] The test substance had a water content of 22.5%,
and all nominal test concentrations were corrected for the water content and expressed as mg
ai/L

.

“Amounts of test item (258 and 82 mg) were each separately dissolved in culture medium and the volume adjusted to 2 litres to give 100 and 32 mg ai /l stock solutions respectively. A series of dilutions was made from these stock solutions to give further s tock solutions of 10, 3.2, and 1.0 mg ai /l . An aliquot (1800 m l ) of each of the stock solutions was separately inoculated with algal suspension (37 m l ) to give the required test concentrations of 1.0, 3.2, 10, 32, and 100 mg
ai /l

.

The stock solutions a nd each of the prepared concentrations were inverted several times to ensure adequate mixing and homogeneity.

The concentration and stability of the test item in the test preparations were verified by chemical analysis at 0 and 96 hours...” [ Vryenhoef and Mullee 2012 , p. 10]

“Six [250 mL glass conical ] flasks each completely filled with test preparation were used for the control and three flasks each completely filled were used for each treatment group.

The control group was maintained under identical conditions but not exposed to the test item.

Pre

- culture conditions gave an algal suspension in log phase growth characterised by a cell density of 4.95 x 10 5 cells per m l . Inoculation of 1800 m l of test medium with 37 m l of this algal suspension gave an initial nominal cell density of 1 x 10 4 cells per m l and had no significant
dilution effect on the final test concentration.” [ Vryenhoef and Mullee 2012 , p. 10]

“The flasks were sealed with ground glass stoppers and incubated (INFORS Multitron® Version 2 incubator) at 24 ± 1 ° C under continuous illumination ( intensity approximately 7000 lux) provided by warm white lighting (380

- 730 nm) and constantly shaken at appr oximately 150 rpm
for 96 hours.

Samples were taken at 0, 24, 48, 72, and 96 hours and the cell densities determined using a Coulter® Multisizer Particle Counter” [ Vryenhoef and Mullee 2012 , p. 11]

“The pH of the control and each test concentration was determined at initiation of the test and after 48 and 96 hours exposure... The temperature within the incubator was recorded hourly using the incubators’ internal pt

- 100 temperature probe and Multicom Software Package.” [ Vryenhoef and Mullee 2012 , p. 11]Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

37 “A re

- growth test was performed after 96 hours to determine the algicidal or algistati c effect o f the test item. Aliquots were removed from each replicate control and test culture (0.25 m l and
0.50 m l respectively) and the replicate s pooled. Fresh sterile culture medium (100 m l ) was added to each to ensure that the test concentration was reduced to below the inhibiting level.

The flasks were plugged with polyurethane foam bungs are [ sic ] incubated ...at 24 ± 1°C under
continuous illu mination (intensity approximately 7000 lux) and constantly shaken at approximately 150 rpm for 168 hours.” [ Vryenhoef and Mullee 2012 , p. 11]

“Samples were taken from the control (replicate s R 1

- R 6 pooled) and each test group (replicate s R 1

- R 3 pooled) at 0 and 96 hours for quantitative analysi s.

Given the volatile nature of the test item, an additional test replicate was prepared for each test concentration at 0 hours and incubated alongside the study remaining unopened. Samples of
these addi tional replicate s were taken for unopened vessel analysis at 96 hours.” [ Vryenhoef and
Mullee 2012 , p. 1 1 ]

“ [A] t the request of the Sponsor all test concentrations were corrected for the [22.5%] water

content. [According to the study authors:] The test i tem was known to degrade immediately in water to form ethanolamine (0.84 mg /l ethanolamine ≡ to 1 mg ai /l ) and formaldehyde (0.41

mg /l formaldehyde ≡ to 1 mg ai /l ). Therefore analysis of the test preparations was [ performed ] for the 2 degradation products only. The ethanolamine concentration in the test samples was determined by high performance liquid chromatography coupled to mass spectrometry (HPLC

MS) using an external standard. The formaldehyde concentration in the test samples was determined by derivatisation with 2,4

- dinitrophenylhydrazine phosphoric acid solution with high performance liquid chromatography (HPLC) using an external standard. The ethanolamine and the formaldehyde gave a chromatographic profile consisting of a single peak

...

A v olume of test sample was diluted (if required) with test medium to give a theoretical concentration of 1 mg ai/1. To 100 ml of this was added 1 ml of 2,4

- dinitrophenylhydrazine phosphoric acid solution* [* Fluka

– 0.2M derivatising agent] and 50 μl of pen tafluoropropionic
acid. The test sample was then shaken to mix and allowed to stand for 15 minutes before analysis for both ethanolamine and formaldehyde. ” [ Vryenhoef and Mullee 2012 , p. 40]

Statistical Analysis: “One way analysis of variance incorporating Bartlett’s test for homogeneity of variance...and Dunnett’s multiple comparison procedure for comparing several treatment with a control...was carried out on the growth rate, yield and biomass integral data after 72 and 96 hours for the control and all test concentrations to determine any statistically significant
differences between the test and control group. All statistical analyses were performed using the SAS computer software package...” [ Vryenhoef and Mullee 201 2 , p p . 14

- 15]

“ For each individual test vessel

... , percentage inhibition (arithmetic axis) was plotted against test concentration (logarithmic axis) and a line fitted by computerised interpolation usi ng the Xlfit software package (ID BS). ECx values were then determined from the equation for the fitted
line. Where appropriate 95% confidence limits for the EC 50 values were calculated, using theFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

38 simplified method of evaluating dose

- effect experiments of Litchfield and Wilcoxon (1949). ” [ Vryenhoef and Mullee 2012, p. 14 ]

Validation Criteria: The results of the test were considered valid by the study authors if the following performance criteria were met: the cell con cen tration of the control cultures must increase by a factor of at least 16 afte r 72 hours and by a facto r of at least 100 after 96 hour s ; the mean of the coefficients of variation of the section by section specific growth rates in the control cultures during the course of the test (0

- 24, 24

- 48, and 48

- 72 hours) must not exceed 35 % ; the
coeffici ent of variation of the average specific growth rate in replicate control cultures after 72
hours must not exc eed 7%; and the coefficient of variation of the cell density values in replicate
control cultures must not exceed 20% after 72 and 96 hour s ).

A p ositive control study was conducted using zinc chloride as the reference item.

RESULTS

Endpoint value(s ): “ Given that toxicity cannot be attributed to a single degradation product or mixture of degradation products it was considered appropriate [by the study authors] to calculate the results based on nominal test concentrations only. ” [ Vryenhoef and Mullee 2012 , p. 6]

The following results were determined from the data based on nominal test concentrations of
CASRN 4719

- 04

- 4 :

72

- h EC 50 (growth ): 5.2 mg ai/ L *
96

- h EC 50 (growth): 4.2 mg ai/L ; 95% con fidence limits 3.9

– 4.6 mg ai/L
96

- h NOEC (growth): 1.0 mg ai/ L
72

- h EC 50 (yield): 3.5 mg ai /L ; 95% confidence limits 3.2

– 3 .8 mg ai /L
96

- h EC 50 ( yield): 3 .2 mg ai /L; 95% confidence limits 3. 0

– 3. 4 mg ai /L
96

- h NOEC (yield) = 1.0 mg ai /L
72

- h EC 50 (biomass): 3. 6 mg ai /L; 95% confidence limits 3.3

– 3.9 mg ai /L
96

- h EC 50 (biomass): 3.3 mg ai /L ; 95% confidence limits 3.1

– 3.6 mg ai /L
96

- h NOEC (biomass) = 1.0 mg ai /L

“ * It was not possible to calculate 95% confidence limits for the E r C 50 value as the data generated did not fit the models available for the calculation of confidence limits.” [ Vryenhoef and Mullee
2012 , p. 18]

Results remarks: Range

- Finding Test: “The results showed no effect on growth at the [nominal] test concentrations of 0.10 and 1.0 mg
ai /l . However, growth was observed to be reduced at 10, 100 and 1000 mg ai /l

.

Based on this information test concentrations of 1.0, 3.2, 10, 32 and 100 mg ai /l were selected for
the definitive test. ” [ Vryenhoef and Mullee 2012 , p. 16]Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

39 Measurements of degradation products : E thanolamine (HPLC

- MS) concentrations were 0.519, 11.0, and 88.6 mg/L at nominal concentrations of 1.0, 10, and 100 mg ai /L, respectively, at 0 hours and 0.379, 11.0, and 85.2 mg/L at nominal concentrations of 1.0, 10, and 100 mg ai/L, respectively, at 96 hours

. F ormaldehyde (HPLC) concentrations were 0.498, 3.95, and 44.2 mg/L at nominal concentrations of 1.0, 10, and 100 mg ai/L, respectively, at 0 hours and 0.0964, 3.13, and 35.6 mg/L at nominal concentrations of 1.0, 10, and 100 mg ai/L, respectively, at 96
hours. “ Only the test concentrations spanning the range of concentrations to be employed in the
definitive test we re analysed. ” [ Vryenhoef and Mullee 2012, p. 16]

Definitive Test: Growth, Yield, and Biomass Integral Data: After 96 hours of exposure, the mean cell density was 1.29, 1.43, 0. 639, 0.00 930

, 0.00 731, and 0.0 114 x 10 6 cells/mL at nominal concentrations of 0, 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively. The mean inhibition of growth rate was

- 1, 15, 102, 107, and 98% at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively.
The mean inhibition of yield was

- 11, 51, 100, 100, and 100% at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively. The mean inhibition of biomass was

- 18, 43, 100, 100, and 100%, respectively, at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively.

“ There were no statistically significant differences between the control and 1.0 mg ai / l test concentration (P ≥ 0.05); however all other test concentrations were significantly different (P < 0.05) and, therefore the “ N o O bserved E ffect C oncentration” (NOEC) based on [ growth rate, yield and biomass integral ] was 1.0 mg ai / l

. Correspondingly the “Lowest Observed Effect Concentration” (LOEC) based on [growth rate, yield, and biomass integral] was 3.2 mg ai/l. ” [Vryenhoef and Mullee 2 0 12 , p p

. 18

- 19 ]

Validation Criteria: “[T]he cell concentration of the control cultures increased by a factor of 73 after 72 hours and by
a factor of 150 after 96 hours

...

The mean coefficient of variation for section by section specific growth rate for the control
cultu res over the test period (0

- 72 h ours ) was 15 %

...

The coefficient of variation for average specific growth rate for the control cultu res over the test period (0

- 72 h) was 3 %

...

The coefficient of variation of th e cell density values in replicate control cultures was 14% after 72 hours and 7% after 96 hours

... ” [Vryenhoef and Mullee 2007, p. 1 7 ]

Obse rv ations on Cultures: “All test and control cultures were inspected microscopically at 96 hours. T here were no abnormalities detected in any of the control or test cultures.” [Vryenhoef and Mullee 20 12 , p. 1 9 ]

Obse rv ations on test material solubili ty: “At the start of the test all control and test cultures were observed to be clear colo u rless
solutions. After the 96

- H our test period all control and 1

. 0 mg ai / l test cultures were observed toFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

40 be bright green dispersions . The 3.2 mg ai/l test cultures were observed to be green dispersions, the 10 mg ai/l test cultures were observed to be extremely pale green dispersi ons whilst the 32 and 100 mg ai / l test cultures were observed to be clear colorless solutions.” [Vryenhoef and Mullee 2007, pp. 19

– 2 0 ]

Physico

- chemical measurements: The range of pH measurements in all cultures was 7.7 to 9.1 at 0 hours, 8.1 to 9.2 at 48 hours,
and 8.2 to 10.3 at 96 hours. “ The pH value of the control cultures

... was observed to increase from pH 7.7 at 0 hours to pH 8.8 at 48 hours and pH 10.2 at 96 hour s. This increase was considered to be due to the amount of carbon dioxide required by the large number of algal cells in the log phase of growth

... Due to the need to test in completely filled and sealed test vessels
there was minimal transfer of CO 2 from th e gaseous phase to the aqueous phase and hence CO 2 required for photosynthesis and growth would be derived from bicarbonate in solution which results in an increase in the pH of the culture. Despite the addition of 500 mg /l of sodium
bicarbonate to the cu lture medium the increase in pH after 96 hours was in excess of that
recommended in the Test Guidelines (1.5 pH units after 96 hours). This was considered to have
had no adverse effect on the results of the study given that the increase in cell concentrat ion in the control cultures exceeded the validation criterion given in the Test Guidelines.” [ Vryenhoef
and Mullee 2012 , p. 20]

Verification of test concentrations: Measured ethanolamine (HPLC

- MS) concentrations were 0.518, 3.17, 11.4, 34.7, and 91.9 mg/L at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively, at 0 hours and 0.343, 2.82, 7.60, 19.6, and 56.8 mg/L at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively, at 96 hours. Measured formaldehyde (HPLC) concentrations were 0.482, 1.5, 4.21, 15.0, and 43.8 mg/L at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively, at 0 hours and 0.110, 0.429, 2.9 6, 10.2, and 30.5 mg/L at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively, at 96 hours.

At initiation of exposure (time = 0 hours), the measured concentrations of monoethanolamine and formaldehyde were 62

- 136% and 102

- 117% of nom inal (expected) concentrations, respectively, assuming complete degradation of each mole of CASRN 4719

- 04

- 4 to produce 3 moles of monoethanolamine and 3 moles of formaldehyde. At the end of exposure (time = 96 hours), the measured concentrations of monoet hanolamine and formaldehyde were 41

- 105% and
27

- 78% of nominal (expected) concentrations, respectively. Therefore, a decline in the concentrations of both degradation products was evident after 96 hours.

In unopened test vessels, measured ethanolamine concentrations were 0.373, 2.68, 7.61, 19.8,
and 57.7 mg/L at nominal concentrations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively, at 96 hours. Measured formaldehyde concentrations in unopened test ves sels were 0.129, 0.511, 2.95, 8.53, and 27.0 mg/L at nominal concent rations of 1.0, 3.2, 10, 32, and 100 mg ai/L, respectively,
at 96 hours. “ These results were similar to the results obtained from the test samples which had been opened on a daily basis a nd hence it was considered [by the study authors] that the decline in concentration observed over the test duration was due to instability rather than volatility. ” [ Vryenhoef and Mullee 2012 , p 21]Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

41 A mass balance calculation for the data obtained for the 100 mg/L, 0

- hour test sample was provided. “The data shows that equimolar concentrations of formaldehyde and ethanolamine
were fou n d, and... the s e were then used independently to calculate and confirm that the concentration of the 1,3,5

- triazine active ingr edient at 0 hours was within the expected limits for the 100 mg/ l test sample” [Vryenhoef and Mullee 2012, p. 50]

Re

- Growth Experiment:

“ A re

- growth test was performed which showed the test item to be algistatic in effect.” [Vryenhoef and Mullee 20 12, p. 21 ]

Positive Control: “The results from the positive control with zinc chloride were within the normal range s for this
reference item .” [Vryenhoef and Mullee 20 12 , p . 38 ]

CONCLUSIONS

“ The effect of the test item on the growth of Pseudokirchneriella subcapitata has been investigated over a 96

- Hour period and gave the following results based on nominal test concentrations : ...” [Vryenhoef and Mullee 2007, p . 2 1 ]

The 72

- hr EC 50 values were 5 .2 mg ai/L for growth rate , 3.5 mg ai/L for yield , and 3.6 mg ai/L for biomass integral

. The 96

- hr EC 50 values were 4.2 mg ai /L for growth rate

, 3.2 mg ai /L for yield , and 3.3 mg ai/L for biomass integral . The 96

- hour NOEC and LOEC were 1.0 and 3.2 mg ai/L, respectively

, for growth rate

, yield

, and biomass integral

.

STUDY RELIABILITY

[2] Reliable with restrictions. The following s tudy deficiencies were noted : (1) The study authors measured the concentrations of the primary degradation products (monoethanolamine and formaldehyde) but did not measure the concentration of the parent test compound (1,3,5

- triazine

- 1,3,5(2H,4H,6H)

- triethanol; CASRN 4719

- 04

- 4); (2) the study authors calculated the
EC 50 values based on nominal, rather than measured, test concentrations; (3) the complete composition of the test substance is not clearly stated in the submitted study report; (4) the loss of monoethanolamine and formaldehyde from solution during the algae test is not clearly explained; and (5) 95% confidence limits were not calculated for the 72

- hour ErC 50 value because the data generated did not fit the models available for the calculation of confidence
limits.

REFERENCE

Vryenhoef, H., and Mullee, D.M. 2012. 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- T riethanol (C AS No.
4719

- 04

- 4 ): Algal Inhibtion Test; Project No. 41103115. Performing Laboratory: Harlan Laboratories Ltd., Shardlow, Derbyshire, UK. Sponsor: Society of Chemical Manufacturers & Affiliates, Washington, DC, USA.

Text in quotes is taken directly from Vryenhoef and Mullee

, 2012.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

42 Study 2 : Toxicity to Selenastrum capricornutum ( Oldersma and Bowmer , 2002)

Title: Determination of the effect of KM200 on the growth of the freshwater green alga Selenastrum capricornutum (OECD 201 and EU C.3 Guidelines)

This study is: Adequate Not Adequate

The study is invalid because: (1) No analytical measures of the test substance were obtained during testing. An appropriate method for performing analytical measurements of the test substance was not used. The test needs to be redone using an appropriate method. (2) The purity of the test substance was less than 100% and information on the composition of the remaining percentage of the test substance was not provided. (3) It is no t clear that the reported nominal concentrations take into account the purity of the test substance.

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4

Remarks: Purity: 70

- 90%; trade name: KM200; clear liquid; B atch no. L11381

METHOD

Method/guideline followed: OECD Guideline 201 and EU C.3 Guidelines

Test type: Static toxicity test to freshwater algae

GLP compliant?: Yes

Year study was performed: 2002

Test species: Green algae ( Pseudokirchneriella subcapitata , formerly Selenastrum capricornutum ); culture supplied by CCAP, The Freshwater Biological Association, Cumbria, England.

Analytical monitoring: No (Analytical monitoring was attempted, but results were not reported.) 1

Exposure duration: 70.5 hours

1 Analytical monitoring was attempted by the study authors. However, d ue to inconsistent results from the chemical analyses, the measured concentrations of test substance were not reported by the study authors. The measurements were considered to be unreliable. See section on Study Reliability for more information.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

43 Concentrations tested: Nominal: 0, 3.2, 10, 18, 32, 56, 101, and 322 mg/L 2 ; measured concentrations were not reported. However, no indication is provided as to whether the
concentrations take into account the 70

- 90% purity of the test substance.

Test method/conditions remarks: After a range

- finding test, a definitive growth inhibition test was conducted. The test medium was prepared in ultra pure water and was sterilized by micropore filtration. The prepared medium contained 150 mg NaHCO 3 /L and had a hardness of 24.3 mg CaCO 3 /L. Test solutions were prepared in medium at nominal concentrations of 0, 3.2, 10, 18, 32, 56, 101, and 322 mg/L.

At test initiation, an inoculum of 1.0 mL of an algal suspension containing 8 x 10 5 cells/mL was added to 200

- mL flasks containing 100 mL of test solution, yielding an initial cell density of 8 x
10 3 cells/mL. The test was carried out in duplicate, with four controls containing algae only and a single set of flasks containing test substance witho ut algae (blanks) at each nominal concentration. All flasks were incubated at 23 ± 2 °C and shaken at approximately 200 rpm on an orbital shaker. The flasks were illuminated using fluorescent lamps at a light intensity of 60

- 120 μmol/s/m 2 (measured with a Bottemanne Weather Instruments Photosynthetic Radiometer RA200 Q).

The initial cell density was calculated from the measured density in the algal pre

- culture used for the inoculation, divided by the appropriate dilution factor. Algal densities (cells /mL) and algal biovolume (μm3/mL) were determined after 23.5, 47, and 70.5 hours using an electronic particle counter (Coulter Multisizer IIe). Measured values were corrected for background values in the appropriate blanks. The mean measured values were used for calculation of effect levels.

The pH was measured at the start (in medium without algae) and after 70.5 hours in selected cultures. The morphology of the algae was examined visually with the aid of a microscope at the
start and end of the test. The light intensity at two different culture positions was measured at
the start of the test.

Samples for chemical analysis of test substance concentrations were taken at the start of the test from control series without algae and at the end of the test from series with algae. Chemical analysis was based on an HPLC method using a fluorescence detector and an external standard. The test substance was fluorogenically labeled with a mixed o

- phtalaldehyde/mercaptoethanol reagent before HPLC analysis.

The EC values with respect to growth rate (E r C values) were calculated by means of a parametric model, assuming exponential growth and a constant error per measurement. The EC values with respect to area under the growth curve (E b C values) were calculated by the method provided in OECD Guideline 201. The values were calculated by linear interpolation of a plot of the percentage reduction in growth (I A ) against the log concentration of the test substance. The NOEC was determined as the highest concentration at which no statistically significant inhibition

2 The nominal concentrations were reported as 0, 3.2, 10, 18, 32, 56, 101, and 322 mg/L in section 2.5.3 and Annex D of the study report, but were reported as 0, 3.3, 10, 18, 33, 57, 102, and 326 mg/L in section 2.5.1 of the study report.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

44 was observed. The effect was considered significant if the average inhibition of the growth rate was higher than 5%. Statistical significance was determined with a one

- tailed t

- test (α = 5%).

RESULTS

Endpoint value(s): Based on nominal concentrations reported: E r C 50 = 62 mg/L; E b C 50 = 33 mg/L; NOEC (growth rate) = 18 mg/L; LOEC (growth rate) = 32 mg/L

Results remarks: The temperature and light intensity were measured to be 23.9

- 24.6 °C (average of 24.0 °C) and 87

- 115 μmol/s/m 2 , respectively. At the start of the test, the pH of each flask was found to be 8.4. At the end of the test, the pH range was 8.2

- 8.3 in the ab sence of algal
cells and 8.2

- 9.1 in the presence of algal cells.

Due to inconsistent results from the chemical analyses of test substance concentrations, the measured concentrations in test solutions were not reported by the study authors. Therefore, the effect levels were determined using nominal concentrations.

After 70.5 hours of exposure, the mean cell density was 76.6, 80.0, 80.1, 76.3, 34.6, 12.4, 1.8,
and 1.3 x 10 4 cells/mL at nominal concentrations of 0, 3.2, 10, 18, 32, 56, 101, and 322 mg/L

,
re spectively. The mean percent reduction in growth rate was

- 7,

- 8,

- 4, 49, 80, 98, and 99% at
nominal concentrations of 3.2, 10, 18, 32, 56, 101, and 322 mg/L , respectively. Calculated biomass values were 65.8, 65.7, 64.7, 59.4, 36.9, 7.0, 0.8, and 0.3 x 10 6 μm 3 /mL at nominal
concentrations of 3.2, 10, 18, 32, 56, 101, and 322 mg/L , respectively. Microscopic inspection of the morphology of algal cells revealed no abnormal cells in treated cultures at the end of the

test.

Based on nominal concentrations, the E r C 50 was found to be 62 mg/L, with a 95% confidence interval of 55 to 70 mg/L. The E r C 10 and E r C 90 were 31 and 120 mg/L, respectively. The E b C 50 was found to be 33 mg/L, with a 95% confidence interval of 32 to 56 mg/L. The E b C 10 and
E b C 90 were 21 and 79 mg/L, respectively. Based on inhibition of growth rate, the NOEC was found to be 18 mg/L.

CONCLUSIONS

A significant reduction in the growth rate of P. subcapitata was observed at a nominal test substance concentration of 32 mg/L. The EC 50 was found to be 62 mg/L based on inhibition of growth rate and 33 mg/L based on reduction in biomass.

STUDY RELIABILITY

[3] Not reliable. The study is not reliable for the following reasons: (1) No reliable analytical
measures of the test substance were obtained during testing. The analytical method attempted
for measuring test substance concentrations during the toxicity test was not appropriate because it relied on rapid hydrolysis of the test substance and, therefore, analytical testing using anFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

45 appropriate method was not conducted; 3 (2) the composition of 10

- 30% of the test substance (described as 70

- 90% pure) is not defined, suggesting that the test substance may contain impurities; (3) it is not clear if the nominal concentrations have been adjusted to account for purity of the tes t substance, such that the concentrations of the test substance reported in the study may be overestimated by as much as 30%; hence, the EC 50 s, NOECs, and LOECs may be overestimated by as much as 30%; and (4) the definitive test used only two replicates pe r test concentration, whereas OECD Guideline 201 recommends three replicates per test concentration.

REFERENCE

Oldersma, H. and C.T. Bowmer. 2002. Determination of the effect of KM200 on the growth of the freshwater green alga Selenastrum capricornutum (OECD 201 and EU C.3 Guidelines). TNO Study Number 02

- 4064/02. Submitted by Troy Corporation.

3 Although the study report states that the test substance is unstable in water and, therefore, the test solutions were undefined mixtures of the test substance and hydrolysis products from the onset of testing, the U.S. EPA Reregistration Eligibility Decision for Grotan (HHT) indicates that the hydrolysis half

- life of CAS No. 4719

- 04

- 4 i s 50 and 302 days at pH 7 and 9, respectively. Therefore, the hydrolysis of the test substance is not expected to be rapid under the test conditions described for the algae study.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

46 D

- 4. Acute Toxicity

Summary of endpoint: Adequate

Study 1: Acute oral toxicity study in rats (Rush, 1989)

Title: Acute Oral Toxicity Study in Rats with Busan 1060

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 79.4% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 20.6 %
unidentified

Remarks: Clear yellow liquid, referred to in the reviews as Busan 1060, HHT, hexahydro

1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, and dihydro

- 5

- (2

- hydroxyethyl)

- 1,3,5

- triazine

- l,3(2 H,4H)

- dipropanol

METHOD

Method/guideline followed: OPPTS 870.1100

Test type: Acute Oral

-- Rat

GLP compliant?: Not indicated

Year study performed: 1989 (issue year)

Test species: Sprague

- Dawley rats, 182 to 219 grams (males) and 173 to 203 grams (females) at study start.

Number of animals/sex/dose: 5

Route of administration: Oral gavage

Vehicle: Distilled water

Doses/concentrations tested: 500, 1000, or 1500 mg/kg

- bw (males) and 500, 750, or 1000 mg/kg

- bw (females).

Statistical methods used: Mortality data were analyzed separately for male and female rats by probit analysis. LD 50 values and 95% confidence intervals were calculated by the method of Litchfield and Wilcoxon (J. Pharmacol. Exp. Ther., 96:99

- 113, 1949). Body weight means and
standard deviations were calculated.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

47 Test method/conditions remarks: Different doses were tested in males and females because a rangefinding study was thought to indicate sex

- related differences in lethality.

RESULTS

All deaths occurred by Day 2 after d osing. Incidences of mortality were 0/5, 2/5, and 3/5 in males at respective doses of 500, 1000, and 1500 mg/kg

- bw and 0/5, 2/5, and 5/5 in females at respective doses of 500, 750, and 1000 mg/kg

- bw.

Frequently observed clinical signs included underactivity, breathing difficulties, prostration, soft stools, “cool

- to

- touch”, decreased fecal production, fecal/urine stains, and dark material around the facial area. In male survivors, mean weight gain was slightly depressed at the mid

- and high
dos es compared with animals at the low dose.

Gross pathology revealed no adverse findings in survivors at any dose level, with the single exception of one 500 mg/kg male that exhibited a dilated renal pelvis. Gross necropsy findings
for animals found dead included: dark red adrenal glands, reddened mucosa of the digestive tract, dark red lymph nodes, and colored fluid/mucoid contents in the digestive tract.

Endpoint value(s): LD 50 (male rats) = 1250 (840

- 1858) mg/kg

- bw; LD 50 (female rats) = 763 (701

- 832) mg/kg

- bw

Results remarks: None specified

CONCLUSIONS

The LD 50 was 1250 (840

- 1858) mg/kg

- bw for male rats and 763 (701

- 832) mg/kg

- bw for female

rats.

STUDY RELIABILITY

[1] Reliable without restrictions.

REFERENCES

Locke, R.K. (1995). H exahydro

- 1 ,3,5

- tris(2

- hydroxyethyl)

- s

- triazine . Review of Toxicity Data.
DP Barcode: D212071. Submission #: S481738. Document No. 011557.

Rush, R.E. (1989). Acute oral toxicity study in rats with Busan 1060. Springborn Laboratories Study No. 3138.47. EPA/O PP MRID 41675206 as cited in Locke (1995).Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

48 Study 2 : Acute oral toxicity study in mice ( Consultox Laboratories, 1973)

Title: Glokill 77: Acute Oral Toxicity

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5% unidentified (Chen and Tao 2008) or purity unstated (Consultox Laboratories 1973).

Remarks: None

METHOD

Method/guideline followed: OPPTS 870.1100

Test type: Acute oral

-- mouse

GLP compliant?: Not indicated

Year study performed: 1973

Test species: Tyler’s original strain white mice, 20 ± 2 g

Number of animals/sex/dose: 5

Route of administration: Oral gavage

Vehicle: Distilled water

Doses/concentrations tested: 0.75, 1, 1.5, 1.75, or 2 mL/kg

- bw

Statistical methods used: Not stated

Test method/conditions remarks: Glokill 77 of unstated purity was diluted to 20% in distilled water and administered by oral gavage to fasted mice. Food and water were available a d libitum. A preliminary range

- finding study, carried out using 2 mice/dose, tested doses of 0.5, 1, 2, 3, 4, or 5 mL/kg

- bw. Animals were observed for 1 week after dosing. Based on the results of the preliminary study (all mice administered ≥ 2 mL/kg

- bw died), a final assay was performed on 5 groups of mice using 10 mice (5/sex/dose). Doses used in the main study were 0.75, 1, 1.5, 1.75, or 2 mL/kg

- bw. Animals were observed for mortality and/or signs of toxicity for 14 days.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

49 RESULTS

In the main study, mortality was 0/10, 2/10, 7/10, 8/10, and 10/10 at respective doses of 0.75, 1, 1.5, 1.75, or 2 mL/kg

- bw. All deaths occurred within 24 hours. Signs of toxicity that occurred within 30 minutes of dosing included disoriented locomotion, loss of activity, and coma.

Endpoint value(s): LD 50 = 0.75, 1, 1.5, 1.75, or 2 mL/kg

.

Results remarks: None specified

CONCLUSIONS

The oral (gavage) LD 50 for mice was 0.75, 1, 1.5, 1.75, or 2 mL/kg in both sexes combined.

STUDY RELIABILITY

[2] Reliable with restrictions. Animal weights were not recorded, animals were not observed daily for signs of toxicity, surviving animals were not examined and necropsied, the LD 50 was not provided for each sex, the method used to calculate the LD 50 was not reported, and the doses in mL/kg

- bw were not converted to mg/kg

- bw.

REFERENCES

Chen, J.; Tao, J. (2008). Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decisio n (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Consultox Laboratories. (1973). Glokill 77: Acute Oral Toxicity. Acc. No. 260195. Unpublished study, 4 p. MRID No. 00155959 As cited in Stewart (1986) a nd Chen and Tao (2008)

.

Stewart, J.E. (1986). Memorandum, Subject: Hexahydro

- 1.3.5

- tris(2

- hydroxyethy1)

- s

- triazine; Bioban GK; Glokill 77, EPA File Symbol 48301

- RU. Document 005165, Caswell No. 481C, Project No. 902.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

50 Study 3: Acute inhalation toxicity study in rats (BASF Corporation, 2010)

Title: Acute Inhalation Study in Wistar Rats (RccHan:WIST(SPF)) with hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine (CAS No. 4719

- 04

- 4)

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 73.3% aqueous 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; not
indicated if test substance contains other chemicals

Remarks: None specified

METHOD

Method/guideline followed: OECD TG 403

Test type: Acute Inhalation Toxicity

GLP compliant?: Not Indicated

Year study performed: Not Indicated

Test species: RccHan:WIST(SPF) Wistar rats

Number of animals/sex/dose: 5

Route of administration: Inhalation, nose

- only

Vehicle: Air

Doses/concentrations tested: 0.26, 0.485, or 1.07 mg/L (measured concentrations)

Statistical methods used: Not stated

Test method/conditions remarks: Groups of 5 rats/sex were exposed nose

- only to a liquid aerosol of the test substance for 4 hours. The surviving animals were observed for clinical signs of toxicity for 14 days.

RESULTS

Within day 1 of the study, 3 of 5 male and all 5 females exposed to 1.07 mg/L died. The surviving animals in this group were in poor condition (apathy or laid on lateral position) and were sacrificed moribund at study day 1. At 0.485 mg/L, 3 of 5 males a nd 3 of 5 females died within 3 days after exposure. At 0.26 mg/L, 1 of 5 males and 2 of 5 females died duringFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

51 exposure or by study day 2. Clinical signs of toxicity included gasping, respiration sound, abdominal respiration, nose discharge, red encruste d nose, salivation, distended abdomen, piloerection, and yellow

- discolored and/or substance

- contaminated fur. Dilated stomach and/or small intestine with gaseous content were seen at necropsy. Histological examination, performed only at 1.07 mg/L, showed moderate to severe diffuse erosion and ulceration of the nasal cavity and larynx with moderate to severe diffuse erosion and ulceration.

Endpoint value(s): LC 50 = 0.371 mg/L for both sexes (0.4 mg/L for males and 0.338 mg/L for females)

Results remarks: No additional details were available from this study abstract.

CONCLUSIONS

The LC 50 (both sexes combined) was 0.371 mg/L. The LC 50 values for males and females were 0.4 and 0.338 mg/L, respectively.

STUDY RELIABILITY

[2] Reliable with rest rictions. Information is needed on the composition and stability of the test
substance.

REFERENCE

TSCATS submission (8EHQ

- 10

- 18183; 88110000067): BASF Corporation, November 18, 2010. Notice in Accordance with Section 8(e): Results of an Acute Inhalati on Study in Wistar Rats with hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine (CAS No. 4719

- 04

- 4) as Liquid Aerosol. [This is an abstract; the full study was not available]Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

52 Study 4: Acute sensory irritation and toxicity study in mice ( Krystofiak, 1994)

Title: Evaluation of the Respiratory Effects from Components of a Metalworking Fluid in Mice

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; purity and composition not indicated

Remarks: Amber liquid thicker than corn oil, referred to in the study as Triazine, CAS No.
4719

- 04

- 4.

METHOD

Method/guideline followed: Unclear. The study in the TSCATS submission suggests that an ASTM method (ASTM 1984) was used but does not explicitly state what method was followed.

Test type: Acute sensory irritation from inhalation of airborne chemicals

GLP compliant?: Not Indicated

Year study performed: Not Indicated

Test species: Pathogen

- free Swiss

- Webster mice, 24

- 28 g

Number of animals/sex/dose: 4 males/concentration

Route of administration: Inhalation, head

- only

Vehicle: Air

Doses/concentrations tested: 55, 103, 204, 332, or 1619 mg/m 3 (measured concentrations); the mass median aerodynamic diameter for the aerosol particles of triazine was 1.41 ± 2.33 μm.

Statistical metho ds used: The maximum change in respiratory frequency (f) that occurred during the 180

- minute exposure period was evaluated with respect to control. Significant responses were plotted as a function of the logarithm of exposure concentration. Least

- squares
regres sion analysis was then conducted to establish concentration

- response relationships (i.e., testing that the slope of the line from regression analysis was significantly different from zero, p < 0.05). These relationships were used to calculate the exposure concentration that resulted in a 50% decrease in respiratory frequency (RD 50 ) in the exposed animals.

Test method/conditions remarks: Concentrations of test substance generated by an aerosol generator were determined at least 5 times during each exposure . Aerosol samples were drawnFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

53 from the test chamber onto glass fiber filters and the filters were weighed before and after sampling to determine test substance concentrations gravimetrically. For each concentration of aerosolized test substance, each of 4 male rats was positioned in a body plethysmograph, which was used to continuously monitor respiration pressure changes of the mouse. The head of each mouse extended through a dental latex dam, positioned with a tape collar. Respiratory frequency (f) was measured every 15 seconds. Tidal volume (VT) and f were plotted as a function of time for each mouse. Each experiment consisted of a 20

- minute control period to establish a baseline value for f, followed by a 180

- minute exposure period. The mice were m onitored for 20 minutes after aerosol generation had ended to assess recovery. After removal from the test chamber, mice were observed for seven days for signs of toxicity.

RESULTS

Triazine produced severe sensory irritation at the start of exposure, with milder sensory irritation seen even at the lowest concentration of 55 mg/m 3 . Immediate decreases in respiratory frequency were noted at the start of exposure and a plateau of response was reached in 20

- 30 minutes. The plateau typically lasted during the remainder of the exposure period. The exposure concentration that resulted in a 50% decrease in respiratory frequency (the RD 50 ) was 137 mg/m 3

.

Mice were noted to have extremely swollen heads after exposure to concentrations of ≥ 103 mg/m 3 . Heads o f one animal each at 103 and 1619 mg/m 3 were so swollen that rubber dams and tape restraints had to be cut to remove them from the exposure chamber; because this removal process caused hind leg paralysis due to neck damage, these animals were euthanized on day 1 postexposure. Overall treatment

- related deaths (including animals killed as noted in the preceding sentence) among the 4 mice/concentration were 1, 2, 2, 2, and 3 at concentrations of 55, 103, 204, 332, and 1619 mg/m 3 , respectively. All spontaneou s deaths occurred on days 2

- 4
of the 7

- day observation period. At 24 hours after exposure, up to 15% loss of body weight was seen in some mice at ≥ 103 mg/m 3 ; animals were breathing through their mouths, gasping, and made noticeable clicking and “chirping ” sounds.

Endpoint value(s): RD 50 = 137 mg/m 3 . Based on spontaneous deaths during the 7

- day observation period, the LC 50 was between 103 and 204 mg/m 3

Results remarks: Triazine is a severe sensory irritant.

CONCLUSIONS

Acute exposure of mice to respirable aerosols of Triazine produced severe sensory irritation, signs of respiratory distress, swollen heads, and deaths at concentrations ≥ 103 mg/m 3 and sensory irritation even at the lowest concentration tested (55 mg/m 3 ). The concentration that

pr oduced a 50% decrease in respiratory frequency (the RD 50 ) was 137 mg/m 3 . Based on spontaneous deaths during the 7

- day post

- exposure observation period, the LC 50 in male mice was between 103 and 204 mg/m 3

.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

54 STUDY RELIABILITY

[2] Reliable with restriction s. Information is needed on the composition and stability of the test
substance.

REFERENCE

ASTM. (1984). American Society for Testing and Materials: Standard Guide for Estimating Sensory Irtritancy of Airborne Chemicals. ASTM Designation E 981

- 84. Philadelphia: ASTM,
1984.

TSCATS submission (8EHQ

- 1194

- 13247; 88950000037): General Motors Corporation, Environmental and Energy Staff, Chemical Hazard Assessment and Toxicology, November 4, 1994. Possible TSCA 8(e) Submission. Krystofiak, S.P. (1994 ). Evaluation of the Respiratory Effects from Components of a Metalworking Fluid in Mice. Submitted to the Graduate Faculty of Environmental and Occupational Health, School of Public Health in partial fulfillment of the requirements for the degree of Mas ter of Science. University of Pittsburgh.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

55 Study 5: Acute dermal toxicity study in rabbits ( Hughes et al., 1985)

Title: Acute dermal toxicity screen in rabbits of Bioban GK

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 79.96 % 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 20.04 % unidentified (Chen and Tao, 2008) or purity not indicated (Hughes, 1985)

Remarks: Yellow liquid with pungent odor, referred to in the reviews as HHT, hexahydro

1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, dihydro

- 5

- (2

- hydroxyethyl)

- 1,3,5

- triazine

- l,3(2H,4H)

- dipropanol, and Bioban GK

METHOD

Method/guideline followed: OPPTS 870.1200

Test type: Acute Dermal

-- Rabbit

GLP compliant?: Not indicated.

Year study performed: 1985 (issue date)

Test species: New Zealand White rabbits. 2.07

- 2.67 kg (males) and 2.27

- 2.59 kg (females) at study start.

Number of animals/sex/dose: 5

Route of administration: Dermal

Vehicle: None

Doses/concentrations tested: 2000 mg/kg

- bw undiluted Bioban GK

Statistical methods used: Mean body weights (Days 0, 8, and 15) and body weight changes
over the 15

- day study period (and standard deviations) were calculated.

Test method/conditions remarks: The exposure site (unabraded clipped flank skin) was occluded with rubber dental dam and exposure continued for 24 hours. Animals were weighed at study initiation (Day 0), Day 8, and at study termination (Day 15). At the end of the exposure period, the rubber dams were removed and an imals were observed for mortality, moribundity, gross systemic toxicity, and dermal irritation once on the day of treatment and twice daily
thereafter.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

56 RESULTS

No animals died on test. With the exception of one male, all animals appeared to be normal and gained weight during the entire study period. Gross necropsies were conducted on all animals at study termination; the one abnormal

- appearing male exhibited mottled lungs, a complete depletion of body fat stores, a green

- purple colored spleen, and a ga ll bladder distended with dark green fluid. Two other animals exhibited pale adrenal glands. None of these findings are considered to be elated to treatment. Dermal irritation, characterized by edema, erythema, necrosis, desquamation, and coriaceousness, w ere seen at the site of application to the skin.

Endpoint value(s): LD 50 >2000 mg/kg

- bw

Results remarks: None specified

CONCLUSIONS

The LD 50 was >2000 mg/kg

- bw. The test substance was irritating to the skin.

STUDY RELIABILITY

[2] Reliable with restrictions. Information is needed on the composition and stability of the test
substance.

REFERENCES

Chen, J.; Tao, J. (2008). Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of t he Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Hughes, T.L. et al. (1985). Acute Dermal Toxicity Screen In Rabbits of Bioban GK. Study No.
85

- 0866

- 21. Hill Top Resea rch, Inc. EPA/OPP MRID 155984 as cited in Locke (1995).

Locke, R.K. (1995). H exahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine . Review of Toxicity Data.
DP Barcode: D212071. Submission #: S481738. Document No. 011557.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

57 Study 6: Acute dermal toxicity study in rats ( Siglin et al., 1989a)

Title: Acute Toxicity Studies with Busan 1060

– Dermal Toxicity

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5 % 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5 % unidentified.

Remarks: Referred to in the study as Busan 1060 and hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- 5

- triazine

METHOD

Method/guideline followed: Not indicated

Test type: Acute Dermal

-- Rat

GLP compliant?: Not indicated

Year study performed: 1989

Test species: Sprague

- Dawley rat, 214

- 235 g

Number of animals/sex/dose: 5

Route of administration: Dermal

Vehicle: None

Doses/concentrations tested: 2000 mg/kg

- bw neat Busan 1060

Statistical methods used: None indicated

Test method/conditions remarks: Rats received a single occlusive dermal application of the test substance (neat) at a dose of 2000 mg/kg

- bw. Animals were observed for clinical signs through day 15, body weights were determined on days 1, 8, and 15, and gross n ecropsy was performed on day 15.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

58 RESULTS

The test substance produced no mortality, signs of toxicity, effects on body weight, or findings at necropsy. Following removal of the occlusive dressing, minimal erythema was seen at the application site but this was resolved by day 5.

Endpoint value(s): LD 50 >2000 mg/kg

- bw

Results remarks: None specified

CONCLUSIONS

The LD 50 was >2000 mg/kg

- bw. The test substance was minimally irritating to the skin.

STUDY RELIABILITY

[2] Reliable with restrictions. Information is needed on the composition and stability of the test
substance.

REFERENCE

Siglin, J.C.; Rush, R.E.; Jenkins, P.K. et al. (1989a). Acute toxicity studies with Busan 1060. In: R.A. Parent (ed.), Acute Toxicity Data, J. Amer Coll. Toxicol., Part B, Vol. 1, No. 3, 1992, pp. 204

- 205.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

59 D

- 5. Repeated

- Dose Toxicity

Summary of endpoint: Adequate

Study 1: Repeated

- dose oral toxicity study in rats ( Hill and Newman, 1990a)

Title: Triazine: 13 Week Oral (Gavage) Toxicity Study in the Rat

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5%
unidentified

Remarks: Clear yellow liquid, referred to in the review as hexahydro

- 1,3,5

- tris(2

- hydroxyethyl) S triazine, Triazine, Grotan, and Bioban GK

METHOD

Method/guideline followed: OPP 82

- 1

Test type: Subchronic Oral Toxicity (Rodent and Non

- Rodent): 90

- Day Study

GLP compliant?: Yes

Year study performed: 1990 (issue date)

Test species: Crl: CD(SD)BR rats

Number of animals/sex/dose: 10

Route of administration: oral gavage

Vehicle: pyrogen

- free sterile water

Exposure duration: 5 days/week, 13 weeks

Doses/concentrations tested: 0 (vehicle control), 10, 50, 100, or 250 mg/kg

- bw/day

Statistical methods used: Analysis of variance was used to evaluate body weights, hematology, and organ weight data. Where p = 0.05, pairwise T tests were used between control and treated groups. Blood chemistry parameters were analyzed using the Kruskal Wallis test. The
Wilcoxo n rank sum test was used to determine significant differences between treated and control groups at p = 0.05.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

60 Test method/conditions remarks: Body weights and food consumption were recorded weekly. Hematology and clinical chemistry parameters were meas ured at study termination. Full necropsy was performed on all animals. Complete histopathology was performed on all control and high dose animals. The stability of the test material was confirmed by analysis on the day of preparation of the test materia l and on days 1, 7, 8, 14, and 29 of the study.

RESULTS

One male at 50 mg/kg

- bw/day and seven females (one each at 0, 50, and 100 mg/kg

- bw/day and four at 250 mg/kg

- bw/day) were found dead during the study period. With the exception of one
female from the high dose group, the decedents had gross changes in the lung and/or thoracic cavity. The lungs in these animals did not collapse upon opening the thoracic cavity and adhesions or fluid was present in the area. Inflammatory changes and vascular conges tions were present in the thoracic viscera. In addition to the thoracic lesions, all decedents from the high dose group showed a white discoloration and prominence of the limiting ridge of the stomach.

There were significant differences in the body weigh t gain and food consumption between treated and control rats. With regard to organ weights, absolute adrenal weights were increased for females at 250 mg/kg

- bw/day; this increase was not significant. In addition, an increase in splenic weight was observe d in all treated males. The sponsor attributes this difference to unusually low weights in control animals.

Grossly, a white discoloration and/or prominence of the limiting ridge of the stomach were present in 10/10 high dose males which were sacrificed at the end of the study. This was also present in the remaining high dose females which survived the duration of the study. In animals receiving 100 mg/kg/day, the change occurred in 3/10 males and 1/10 females.

A treatment

- related distribution of lesio ns was in the stomach and to a lesser degree in the liver. In the stomach, erosion of the glandular mucosa was observed in 4/10 males and 2/10 females at 250 mg/kg

- bw/day. This finding was also present in one male at 100 mg/kg. Lymphocytic
infiltration was reported in rats at 100 mg/kg

- bw/day (1/10 males and 2/10 females) and at 250 mg/kg

- bw/day (4/10 males and 6/10 females). Epithelial hyperplasia was reported in three animals at 250 mg/kg

- bw/day (1/10 males and 2/10 females) and in the controls (1/10 females), but there was no statistical significance for this finding.

In the liver, the incidence of hepatocyte vacuolation was increased in high

- dose male rats when compared to other groups. On the other hand, margination of hepatocyte cytoplasm was mor e pronounced in animals at 0 and 10 mg/kg

- bw/day than in rats at 50, 100, or 250 mg/kg

- bw/day.

A high frequency of peribronchiolar lymphoid hyperplasia was reported for all groups. The incidence of this finding ranged from 70 to 100 percent on both sex es. While this finding is not
believed to be treatment

- related, the sponsor has not addressed its significance.

A statistically significant reduction in hematocrit was found in all treated males. Additionally, males at 100 mg/kg

- bw/day demonstrated a st atistically

- significant decrease in hemoglobinFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

61 concentration. Although these findings were statistically significant, they were within the expected laboratory range.

Significant differences in blood chemistry values included reduced bilirubin in all treated groups, reduced total protein in both sexes of rats at 250 mg/kg, and a statistically significant increase in sodium concentration for all treated males and for females at 50, 100, or 250 mg/kg

- bw/day. The bilirubin and total protein values were w ithin the normal range and were not considered to be biologically significant.

Urinalysis was unremarkable and no treatment

- related ocular lesions were present.

Endpoint value(s): LOAEL = 100 mg/kg

- bw/day based on gastric lesions (erosion of the

mucosa and lymphocytic infiltration) in males and females; NOAEL = 50 mg/kg

- bw/day

Results remarks: Microscopic examinations were conducted on all tissues from control and high

- dose animals, tissues from animals that died on study, gross lesions. No treatment

- related histological effects were seen in the following reproductive organs: testes, epididymides, prostate, seminal vesicle, ovaries, uterus, and vagina.

CONCLUSIONS

The LOAEL and NOAEL were 100 and 50 mg/kg

- bw/day, respectively.

STUDY RELIABILITY

[2] Reliable with restrictions. While not expected to affect the outcome of this study, the sponsor should address the significance of the high incidence of peribronchiolar lymphoid hyperplasia as it related to the overall health of the test animals. Fo r animals that died during the study, gross necropsy and microscopic examinations revealed that test substance had entered the lungs in 6 of the 7 decedents; aspiration pneumonia likely resulted from failure to correctly administer the test compound.

REFE RENCES

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED)
Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Hill, R.; Newman, A. (1990a) Triazine: 13 Week Oral (Gavage) Toxicity Study in the Rat: Lab Project Number: LEF/3/90: LEF/3/89. Unpublished study prepared by Toxicol. Laboratories,
Ltd. EPA/OPP MRID 41483001.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

62 Study 2: Repeated

- dose de rmal toxicity study in rats ( Thomas and Brooks, 1984)

Title: Glokill 77: 21 Day Dermal Toxicity Study in the Rat

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 94.8% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 5.2 % unidentified (Thomas and Brooks 1984) or 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol,
CAS No. 4719

- 04

- 4; 21.5% unidentified (Chen and Tao 2008)

Remarks: Clear viscous liquid, referred to in the reviews as Glokill 77 and hexahydro

- 1,3,5

- tris(2

- hydroxyethyl) S triazine

METHOD

Method/guideline followed: Not indicated

Test type: Subacute repeated

- dose toxicity

GLP compliant?: Not stated

Year study performed: ~1984

Test species: Sprague

- Dawley rats

Number of animals/sex/dose: 5

Route of administration: Dermal

Vehicle: None. The test material was used undiluted as supplied.

Exposure duration: 6 hours/day, 21 days

Doses/concentrations tested: 0 (sterile distilled water control), 100, 500, or 1000 mg/kg

bw/day

Statistical methods used: Not stated

Test method/conditions remarks: Identity and stability of the test material were not determined by the investigating laboratory. The test compound was held in contact with the skin by a porous gauze dressing covered with an Elastoplast elastic adhesive ba ndage. At the end of each 6

- hour exposure period the bandage and dressing were removed and the exposure site washed and dried. The test site of each animal was observed daily for local dermal irritation. Animals were observed daily for toxic signs. Ani mals that died during the study were subjected to a detailedFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

63 postmortem examination, and tissues were preserved for histopathological examination. Body weight was recorded immediately prior to the start of the study, and twice weekly thereafter.
Food cons umption was recorded weekly. Water consumption was monitored daily. Hematology and serum biochemical determinations were conducted on a separate group of 10 animals (5 male, 5 female) from the same stock prior to start of the study, and on all test and c ontrol animals at termination of the study. Determinations were done for hemoglobin, erythrocytes, hematocrit, mean corpuscular volume, leukocytes (total and differential) and prothrombin time. Mean corpuscular hemoglobin and mean corpuscular hemoglobin concentration was calculated. Blood chemistry values were determined for blood urea nitrogen, total protein, albumin, A/G ratio, creatinine, total bilirubin, alkaline phosphatase, SGPT, SGOT, gamma glutamyltranspeptidase, glucose, calcium, potassium, sodi um chloride, and phosphate. At termination of the study, all surviving animals were necropsied and terminal weights taken on liver, kidney, adrenals, and gonads. Histopathology was done on liver, kidney, lymph nodes, skin (treated and untreated) and orga ns showing lesions or change in size. Skin was examined histologically in all treatment groups, since compound

- related changes were observed in the high

- dose group.

RESULTS

No animals died during the study. No toxic signs were reported except for local dermal irritation, which was dose

- related and increased in severity with the duration of the study. All groups of treated males gained less weight than corresponding controls. Male weight gain in all groups was approximately 70% of the control male weight gain. The weights observed for all three dosed groups were within the range normally observed in the investigators’ laboratory, and therefore were not considered treatment related. Weight gain was comparable in control and
treated females.

No di fference in food consumption was reported between control and treated males, but during week 1, the mid and high

- dose female food consumption was significantly decreased (p < 0.05) when compared to the controls. No intergroup differences in water consumpt ion were reported. Mean corpuscular volume was reduced in the low and high

- dose males, and hemoglobin was reduced in the low and high

- dose females, but the reductions were not considered biologically significant because they were within the normal range of values for Sprague

- Dawley rats in the investigators’ laboratory.

The following statistically significant changes were noted in the treated animals when compared to the controls (p <0.05): increased protein in mid and high dose males and high dose females

, increased sodium in all treated male groups, increased phosphate in mid and high dose females, increased AST in mid and high dose males, decreased A/G ratio in mid and high dose males and high dose females, and decreased chloride in mid and high dose fem ales. These changes were considered biologically insignificant because the values observed were within the range observed in the animals used in the hematology and biochemical screens. Except for multifocal scab
formation at treatment sites at all dose l evels, no macroscopic abnormalities were reported. Absolute adrenal weight was significantly decreased in low and high

- dose males and was reported to be due to two control animals with high adrenal weights. No difference was reported in relative organ wei ghts. Treatment

- and dose

- related histopathological changes seen at treatedFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

64 skin sites included epidermal ulceration, acanthosis, and dermal inflammatory infiltration with occasional necrosis and hemorrhage. No histological changes were found in other tis sues.

Endpoint value(s): LOAEL (systemic toxicity) > 1000 mg/kg

- bw/day based on no effects at the highest dose tested; NOAEL = 1000 mg/kg

- bw/day. LOAEL (application site irritation) = 100 mg/kg

- bw/day based on epidermal ulceration, acanthosis, and derma l inflammatory infiltration with occasional necrosis and hemorrhage at the lowest dose tested ; NOAEL = Not established

Results remarks: Reproductive organs were not examined histologically in this study.

CONCLUSIONS

The LOAEL for systemic toxicity was > 1000 mg/kg

- bw/day, based on no effects at the highest dose tested, and the NOAEL was 1000 mg/kg

- bw/day. The LOAEL for irritation at the site of test compound application was 100 mg/kg

- bw/day, the lowest dose tested, based on epidermal hyperplasia and ulc eration; a NOAEL was not established.

STUDY RELIABILITY

[2] Reliable with restrictions. The 21

- day duration of this study was shorter than the 28

- day duration needed to adequately address the repeated

- dose endpoint. Also, different values for percent active ingredient were reported in the reviews that formed the basis for this robust summary. In addition, a limited number of organs was preserved and examined histologically.

REFERENCE

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- T riazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Thomas, M.; Brooks, P. (1984) Glokill 77: 21 Day Dermal Tox icity Study in the Rat: Experiment No. 508/8411. Unpublished study prepared by SafePharm Laboratories Ltd.
EPA/OPP MRID 155989Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

65 Study 3: Repeated

- dose dermal toxicity study in rats ( Hill and Newman, 1990b)

Title: 13 Week Dermal Toxicity Study in the Rat

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5%
unidentified

Remarks: Clear yellow liquid, referred to in the review as hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)
S

- triazine, Triazine, Grotan, and Bioban GK

METHOD

Method/guideline followed: OPP 82

- 3

Test type: Subchronic Dermal Toxicity 90

- Day Study

GLP compliant?: Yes

Year study performed: 1990 (issue date)

Test species: Crl:CD(SD)BR rats weighing 197

- 234 g (females) and 230

- 276 g (males)

Number of animals/sex/dose: 10

Route of administration: dermal

Vehicle: pyrogen

- free sterile water

Exposure duration: 5 days/week, 13 weeks

Doses/concentrations tested: 0 (vehicle control), 5, 50, or 250 mg/kg

- bw/day

Statistical methods used: Analysis of variance was used to evaluate body weights, hematology, and organ weight data. Where p = 0.05, pairwise T tests were used between control and treated groups. Blood chemistry parameters were analyzed using the Kruskal Wallis test. The Wilcoxon rank sum test was used to determine significa nt differences between treated and control groups at p = 0.05.

Test method/conditions remarks: During the exposure period, the application sites were
covered with semi

- occlusive bandages and animals were fitted with Elizabethan collars to minimize ingest ion of the test chemical. The test site was not washed between doses. Hematology and clinical chemistry parameters were measured at study termination. FullFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

66 necropsy was performed on all animals. Complete histopathology was performed on all control
and high dose animals. Normal and treated skin from all animals in all dose groups was examined histologically.

RESULTS

No deaths were reported during the study. The clinical signs observed during the study included periorbital, perianal, and cranial fur s taining in all groups; yellow staining at the applications site in animals at 5 and 50 mg/kg

- bw/day, and skin reactions at the application site in animals at 50 and 250 mg/kg

- bw/day. Occasional incidences of erythema were observed in female rats that

rece ived 5 mg/kg

- bw/day.

In assessing the severity of the dermal lesions, erythema was scored as very slight to severe in animals at 50 and 250 mg/kg

- bw/day. An increase in the numbers of animals affected and an increase in the severity of the reported reactions occurred at 250 mg/kg

- bw/day. Moderate to very severe edema was present in animals at 250 mg/kg

- bw/day. At 50 mg/kg

- bw/day, only isolated incidences of edema were reported.

Statistically significant differences were found in blood chemistry values from individual animals. At 5 mg/kg

- bw/day, affected parameters included one male with increased alanine aminotransferase, one female with increased phosphorous and one female with increased chloride. At 50 mg/kg

- bw/day, blood chemistry parameters were increased in two animals. One female in this group had increased sodium and one male had increased chlorine levels. At 250 mg/kg

- bw/day, one female had elevated glucose levels and one male had elevated sodium levels.

Microscopically, there was an increase in the incidence of epidermal hyperplasia and ulceration of the treated area of the skin in animals treated with 50 or 250 mg/kg

- bw/day. Eighty to 100 percent of both the treated and control animals were found to have peribronchiolar lymphoid hype rplasia in the lungs. The significance of the lesions was not discussed.

Endpoint value(s): LOAEL (systemic toxicity) > 250 mg/kg

- bw/day based on no effects at the highest dose tested; NOAEL = 250 mg/kg

- bw/day. LOAEL (application site irritation) = 50

m g/kg

- bw/day based on epidermal hyperplasia and ulceration; NOAEL = 5 mg/kg

- bw/day

Results remarks: Microscopic examinations were conducted on all tissues from control and high

- dose animals, tissues from animals that died on study, gross lesions. No treat ment

- related histological effects were seen in the following reproductive organs: testes, epididymides, prostate, seminal vesicle, and ovaries.

CONCLUSIONS

The LOAEL for systemic toxicity was > 250 mg/kg

- bw/day, based on no effects at the highest
dose t ested, and the NOAEL was 250 mg/kg

- bw/day. The LOAEL for irritation at the site of test compound application was 50 mg/kg

- bw/day based on epidermal hyperplasia and ulceration and the NOAEL was 5 mg/kg

- bw/day.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

67 STUDY RELIABILITY

[2] Reliable with restric tions. While not expected to affect the outcome of this study, the sponsor should address the significance of the high incidence of peribronchiolar lymphoid hyperplasia found in the lungs of both treated and control animals.

REFERENCE

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Hill, R.; Newman, A. (1990b) Triazine: 13 Week Dermal Toxicity Study in the Rat: Lab Project Number: LEF/4/89. Unpublished study prepared by Toxicol Laboratories, Ltd. EPA/OPP MRID
41483002.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

68 D

- 6. Genetic Toxicity

– Gene Mutation

Summary of endpoint: Adequate

Study 1: Mutagenicity study in Salmonella typhimurium ( Mortelmans et al., 1986)

Title: Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4, purity not indicated

Remarks: Referred to in Table I of Mortelmans et al. (1986) as hexahydro

- 1,3,5

- tris(hydroxyethyl)

- s

- triazine.

METHOD

Method/guideline followed: Standard NTP Protocol for the Salmonella/E. coli Mutagenicity
Test or Ames Test.

Test type: Ames Salmonella reverse gene mutation assay

GLP compliant?: Not indicated

Year study performed: 1983

Test species: Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537

Metabolic activation: With and without (tested separately with S

- 9 metabolic activation from rat and hamster livers)

Concentrations tested: 0 (water vehicle control) and at least five concentrations in the range 0.1 to 333 μg/ plate

Statistical methods used: None

Test method/conditions remarks: In the standard protocol (preincubation) for conducting the Ames assay, a test tube containing a suspension of one strain of Salmonella typhimurium (or E. coli ) plus S9 mix or plain buffer without S9, is incubated for 20 minutes at 37o C with the test chemical. Control cultures, with all the same ingredients except the test chemical, are also incubated. In addition, positive control cultures are prepared; these contain the particular bacterial tester strain under investigation, the various culture ingredients, and a known potent mutagen. After 20 minutes, agar is added to the cultures and the contents of the tubes are thoroughly mixed and poured onto the surface of Petri dishes containing standard bacterial culture medium. The plates are incubated, and bacterial colonies that do not require an excess ofFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

69 supplemental histidine appear and grow. These colonies are comprised of bacteria that have undergone reverse mut ation to restore function of the histidine

- manufacturing gene. The number of colonies is usually counted after 2 days. All assays are repeated no less than one week after completion of the initial test.

Criteria for data evaluation were as follows: (1) Mu tagenic response: a concentration

- related, reproducible increase in the number of revertants over background, even if the increase was less than twofold; (2) Nonmutagenic response: when no increase in the number of revertants was elicited by the chemical ; and (3) Questionable response: when there was an absence of a clear

cut concentration

- related increase in revertants, when the concentration

- related increases in the number of revertants were not reproducible, or when the response was of insufficient ma gnitude to support a determination of mutagenicity.

In a preliminary concentration

- setting experiment, 1,3,5

- triazine

- 1,3,5(2H,4H,6H)

- triethanol was
tested with S. typhimurium strain TA100 in the presence and absence of the metabolic activation systems, ov er a wide concentration range with an upper limit of 10 mg/plate. The high concentration for further testing was selected to exhibit some degree of toxicity. One or more of the following was taken as evidence of toxicity: appearance of his

pinpoint col onies, reduced numbers of revertant colonies per plate, or thinning or absence of the bacterial lawn.

Positive control substances were tested concurrently. Failure of the positive controls to induce mutation was considered reason to discard the experimen t.

RESULTS

In S. typhimurium strain TA100, 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol induced a
concentration

- related increase in revertants of up to 2

- fold in the presence of metabolic activation from rat or hamster liver; no increase was observed in th e absence of metabolic activation. The test substance was not mutagenic in strains TA98, TA1535, or TA1537 in the absence or presence of metabolic activation.

Genotoxicity result: Weakly positive

Cytotoxic concentration (if applicable): ≥ 100 μg/plate

Results remarks: Concurrent positive controls produced the expected mutagenic response.

CONCLUSIONS

1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol was mutagenic in S. typhimurium strain TA100 in the presence but not the absence of metabolic activation. The test substance was not mutagenic in S. typhimurium strains TA98, TA1535, or TA1537 with or without metabolic activation.

STUDY RELIABILITY

[1] Reliable without restrictions. The study followed the Standard NTP Protocol for the
Salmonella /

E. coli Mutagenicity Test or Ames Test.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

70 REFERENCES

Mortelmans, K. et al. 1986. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Envir. Mutag. Vol. 8, Suppl. 7:1

- 119.

National Toxicology Program 1983. Salmonella: Study Summary for 1,3,5

- Triazine

1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4. Study ID 700221.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

71 Study 2 : Mutagenicity study in Salmonella typhimurium (NTP, 2004)

Title: Salmonella study for 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4, purity not indicated

Remarks: None

METHOD

Method/guideline followed: Standard NTP Protocol for the Salmonella / E. coli Mutagenicity
Test or Ames Test.

Test type: Ames Salmonella reverse gene mutation assay

GLP compliant?: Not indicated

Year study performed: 2004

Test species: Salmonella typhimurium strains TA98 and TA100

Metabolic activation: With and without (tested separately with S

- 9 metabolic activation from rat and hamster livers)

Concentrations tested: 0 (water vehicle control) and at least five concentrations in the range 10 to 500 μg/plate

Statistical methods used: None

Test method/conditions remarks: In the standard protocol (preincubation) for conducting the Ames assay, a test tube containing a suspension of one strain of Salmonella typhim urium (or E. coli ) plus S9 mix or plain buffer without S9, is incubated for 20 minutes at 37o C with the test chemical. Control cultures, with all the same ingredients except the test chemical, are also incubated. In addition, positive control cultures are prepared; these contain the particular bacterial tester strain under investigation, the various culture ingredients, and a known potent mutagen. After 20 minutes, agar is added to the cultures and the contents of the tubes are thoroughly mixed and poured onto the surface of Petri dishes containing standard bacterial culture medium. The plates are incubated, and bacterial colonies that do not require an excess of supplemental histidine appear and grow. These colonies are comprised of bacteria that have
unde rgone reverse mutation to restore function of the histidine

- manufacturing gene. The number of colonies is usually counted after 2 days. All assays are repeated no less than one week after completion of the initial test.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

72 Criteria for data evaluation were as follows: (1) Mutagenic response: a concentration

- related, reproducible increase in the number of revertants over background, even if the increase was less than twofold; (2) Nonmutagenic response: when no increase in the number of revertants was
elicite d by the chemical; and (3) Questionable response: when there was an absence of a clear

cut concentration

- related increase in revertants, when the concentration

- related increases in the number of revertants were not reproducible, or when the response was o f insufficient magnitude to support a determination of mutagenicity.

In a preliminary concentration

- setting experiment, 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol
was tested with S. typhimurium strain TA100 in the presence and absence of the metabolic
activ ation systems, over a wide concentration range with an upper limit of 10 mg/plate. The high concentration for further testing was selected to exhibit some degree of toxicity. One or more of the following was taken as evidence of toxicity: appearance of his

pinpoint colonies, reduced numbers of revertant colonies per plate, or thinning or absence of the bacterial lawn.

Positive control substances were tested concurrently. Failure of the positive controls to induce
mutation was considered reason to disc ard the experiment.

RESULTS

In S. typhimurium strain TA100, 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol induced a
concentration

- related increase in revertants up to 4

- fold in the absence of metabolic activation and up to 2

- fold in the presence of metaboli c activation from rat liver; no increase was observed
with metabolic activation from hamster liver. In S. typhimurium strain TA98, 1,3,5

- Triazine

1,3,5(2H,4H,6H)

- triethanol induced a concentration

- related increase in revertants up to 2

- fold in the presenc e of metabolic activation from hamster liver but no increase in the absence of activation or the presence of metabolic activation from rat liver.

Genotoxicity result: Positive

Cytotoxic concentration (if applicable): ≥ 1000 μg/plate for strain TA100 and ≥ 333 μg/plate
for strain TA98

Results remarks: Concurrent positive controls produced the expected mutagenic response.

CONCLUSIONS

1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol was mutagenic in S. typhimurium strains TA98 and TA100 in the presence of metabolic activation and was mutagenic in strain TA100 in the absence
of metabolic activation.

STUDY RELIABILITY

[1] Reliable without restrictions. The study followed the Standard NTP Protocol for the
Salmon ella /

E. coli Mutagenicity Test or Ames Test.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

73 REFERENCE

National Toxicology Program 2004. Salmonella: Study Summary for 1,3,5

- Triazine

1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4. Study ID A17569.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

74 Study 3 : Mutagenicity study in Salmonella typhimurium ( Asquith, 1989a)

Title: Bacterial Reverse Mutation Assay: Triazine

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5% not specified

Remarks: Clear yellow liquid, referred to in the review as Triazine and hexahydro

- 1,3,5

- tris(hydroxyethyl)

- s

- triazine.

METHOD

Method/guideline followed: OPPTS 870.5100

Test type: Ames Salmonella reverse gene mutation assay

GLP complian t?: Yes

Year study performed: 1988

Test species: Salmonella typhimurium strains TA98, TA100, TA1535, TA1537, and TA1538

Metabolic activation: With and without

Concentrations tested: 0 (distilled water control), 0.32, 1.6, 8, 40, or 200 μg/ plate

Statistical methods used: The number of revertant colonies per plate was counted electronically (Biotran III), treatment group means and standard deviations calculated, and resulting data statistically analyzed by ANOVA (F

- statistic). If F was significan t (p < 0.05) and
concentration

- responsiveness apparent, a correlation coefficient was calculated over the response range, and its significance read from standard (published) tables. It’s considered a substance positive if it produces a reproducibly statis tically significant increase in the mean number of revertants that exceeds twice the concurrent solvent control, plus evidence for a concentration

response. Plates showing evidence of severe toxicity (markedly reduced or absent background bacterial lawn) were excluded from analysis, since these may yield significantly decreased revertant colony counts (of no relevance to mutagenic activity), or increased colonies from surviving non

- revertant cells incorporating the histidine available because of (toxic) l ysis (i.e., a
false

- positive result).

Test method/conditions remarks: Following a range

- finding toxicity testing with TA98 (only) at concentrations up to 5000 μg/plate, triplicate cultures of all five Ames strains were exposed to the test substance for 72 hours (extended from the customary 48 hours because theFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

75 test substance is bacteriostatic, thus slowing growth of revertant colonies) at each of five concentrations, both in the absence and presence of a mammalian metabolic activation system consisting of the liver microsomal fraction (S9) prepared from male Fischer 344 rats induced by Aroclor 1254 and containing 44 mg protein per mL, plus generating cofactors.

In addition to solvent controls (DW), bacterial strains were exposed to their selectively

approp riate active mutagens in the absence of activation (Sodium azide, 1 μg/plate for TA1535 and TA100; 9

- amino

- acridine, 50 μg/plate for TA1537; 2

- nitrofluorene, 0.5 μg/plate for TA1538 and TA98), but all to 2

- aminoanthracene (2

- AA, 2 μg/plate) under activatio n, thus serving as positive controls. The entire experiment was repeated.

RESULTS

In the preliminary toxicity test, the test substance was toxic to both non

- activated and activated TA98 cells at concentrations of 200 μg/plate and above, as revealed by reduced background lawn indicative of restricted growth. Hence, the five concentrations selected for the mutation assays were 200, 40, 8, 1.6, and 0.32 μg/plate with or without S9 mix.

In both experiments, the test substance consistently reduced backgro und lawns at the HOT, 200 μg/mL, in the absence of activation but with one exception did not induce significantly increased revertant colony counts. The exception was a significant F

- value (p < 0.05) calculated for unactivated TA1537 cultures, derived fro m a wider

- than

- usual variation in mean numbers of revertants on test plates (3.3 to 7.7) compared to the concurrent mean control value (4.7). This was discounted by the investigator because there was neither a doubling of revertant rate nor
evidence of a concentration

- response relationship.

Genotoxicity result: Negative

Cytotoxic concentration (if applicable): ≥ 200 μg/plate

Results remarks: Positive controls were tested but responses to controls were not provided in
the OPP review.

CONCLUSIONS

The test substance was not mutagenic in the Ames testing at levels up to levels of toxicity.

STUDY RELIABILITY

[1] Reliable without restriction.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

76 REFERENCES

Asquith, J. (1989a) Triazine Joint Venture: Bacterial Reverse Mutation Assay: Triazine: Toxicol Study No. M/AMES/10658. Unpublished study prepared by Toxicol Laboratories Ltd. EPA/OPP MRID 41231702. As cited in an EPA OPP Data Evaluation Report by Irving Mauer, January 1990.

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazin e: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

77 Study 4 : Mutagenicity study in Salmonella typhimurium ( Safe Pharm Laboratories, 1984)

Title: Ames Test (O.E.C.D.) Product Glokill 77.

The study is: Adequate Not Adequate

This study is not adequate because: 1) no results were provided for Salmonella typhimurium strain TA1537; 2) results of assays in strains TA98 and TA1538 were inconclusive; and 3) the purity and composition of the test substance were not provided.

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4 of unspecified purity and composition

Remarks: Referred to in the review as Glokill 77

METHOD

Method/guideline followed: Ames et al. and Gardner et al.

Test type: Ames Salmonella reverse gene mutation assay

GLP compliant?: Not indicated

Year study performed: 1984

Test species: Uncertain. The Materials and Methods section of the review of this study in Stewart (1986, pp. 34

- 37) indicates that Salmonella typhimurium strains TA98, TA100, TA1535, and TA1537 were tested. However, the results section provides results for strains TA98, TA100, TA1535, and TA 1538 but not for TA1537.

Metabolic activation: With and without

Concentrations tested: 0 (distilled wa ter control), 0.16, 0.8, 4, 20, or 100 μg/ plate

Statistical methods used: Not indicated.

Test method/conditions remarks: In the main study, each concentration was tested in triplicate, with and without metabolic activation. The test substance was cons idered mutagenic if it produced a dose

- related and statistically significant increase in mutation rates (of at least twice the spontaneous reversion rate) in one or more strains of bacteria in the presence and/or absence
of the S

- 9 microsomal enzymes. Conversely, if the number of induced revertants compared to spontaneous revertants were less than twofold at all dose levels employed up to the limit of toxicity or solubility, the test compound was considered not to be mutagenic.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

78 RESU LTS

No significant increase in the number of revertant colonies was reported for TA100 and TA1535
strains of Salmonella typhimurium ; however, in strain TA98 a significant increase in the number of revertant colonies was reported in the assay with metabo lic activation, and in strain TA1538 an increase in the number of revertant colonies was reported both with and without
metabolic activation.

In strain TA 98, the test compound caused an increase in the mutation frequency. In the first experiment, although the increase in mutation frequency was significantly increased over the spontaneous mutation frequency in untreated bacteria, the mean numbe r of revertant colonies remained the same at all dosage levels in the study using metabolic activation. At the highest dosage level, 100 μ g/plate, the test compound appeared to be cytotoxic. In experiment 2, the mean number of revertant colonies doubled, but the two highest dose levels had lower mutation frequencies than the two middle dose; thus the mutation frequency in strain TA 98 did not seem
to be dose related.

In strain TA 1538, in experiment 1 without metabolic activation, the mutation frequency was significantly increased in a dose

- dependent manner up to the high dose (100 μ g/plate) which appeared to be cytotoxic. In the assay with metabolic activation, the increase in revertant colonies did not appear to be dose related. The highest dose level in this assay appeared to be cytotoxic. In the second experiment, the two highest dosage levels produced a small increase in the number of revertant colonies when the assay was performed without metabolic activation. When the assay was done with metabolic activation the increase in the number of revertant
colonies was dose related.

In summary, the results of the assays in strains TA 98 and TA 1538 of Salmonella typhimurium were not reproducible. Based on this, the results of the study seem to be inconclusi ve.

Genotoxicity result: Inconclusive

Cytotoxic concentration (if applicable): ≥ 100 μg/plate

Results remarks: Positive controls were tested and provided the expected responses. Test concentrations were chosen based upon the results of a preliminary cytotoxicity study.

CONCLUSIONS

The results of this Ames Salmonella reverse gene mutation assay were inconclusiv e.

STUDY RELIABILITY

[3] Not reliable. No results were provided for S. typhimurium strain TA1537. Results of assays in strains TA98 and TA1538 were inconclusive. The purity and composition of the test substance were not provided.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

79 REFERENCES

Safe Pharm Laboratories. (1984). Ames Test (O.E.C.D.) Product Glokill 77. Acc. No. 260195. September 11, 1984. As cited in Stewart (1986).

Stewart, J.E. (1986). Memorandum, Subject: Hexahydro

- 1.3.5

- tris(2

- hydroxyethy1)

- s

- triazine; Bioban GK; Glokill 7 7, EPA File Symbol 48301

- RU. Document 005165, Caswell No. 481C, Project No. 902.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

80 D

- 7. Genetic Toxicity

– Chromosomal Aberrations

Summary of endpoint: Adequate

Study 1: Micronucleus study in mice ( Asquith, 1989b)

Title: Mouse Micronucleus Test: Triazine

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5% not specified

Remarks: Clear yellow liquid, referred to in the review as Triazine and hexahydro

- 1,3,5

- tris(hydroxyethyl)

- s

- triazine.

METHOD

Method/guideline followed: OPPTS 870.5385

Test type: Mouse bone marrow chromosomal aberration test

GLP compliant?: Yes

Year study performed: 1988

Test species: CD

- 1 mice, 5/sex/dose

Metabolic activation: N/A

Doses tested: Single gavage dose of 0 (0.9% NaCl control), 200, 400, or 800 mg/kg

Statistical methods used: The micronuclei data were analyzed by the Mann

— Whitney U

— test, with probabilities for significant differences between test and control groups obtained from standard published tables.

Test method/conditions remarks: Following a range

- finding study (at doses up to 2000 mg/kg), test substance was administered to groups of CD

- 1 mouse by gavage in a single dose and the animals were sacrificed 24, 48, or 72 hours later. Control groups received 0.9% saline (solvent control), or cyclop hosphamide (CPA, positive control); the latter were sacrificed only at 24 hours. Femoral bone marrow harvested at scheduled sacrifice times was prepared for microscopic examination by conventional cytological techniques. At least 1000 polychromatic eryth rocytes (PCE) per animal were scored for micronuclei (MN

— PCE), and the ratio of PCE to normochromatic erythrocytes (NCE) also recorded for each animal.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

81 RESULTS

In the range

- finding test, deaths occurred at 1200 and 2000 mg/kg (respectively, 2 of 3 anim als and 3 of 3 of each sex), but no mortalities at 800 mg/kg or below, providing an estimated LD 50 of approximately 1000 mg/kg. Based upon the (OECD) convention of applying 80% of the LD 50 as the maximum tolerated dose (MTD) for this type of study, the hi ghest dose tested (HDT) for the main study was selected as 800 mg/kg, with two lower doses of 400 and 200 mg/kg.

In the micronucleus assay itself, two high

- dose (800 mg/kg) animals (one of each sex) died
before their scheduled sacrifice at 48 hours. No c ytotoxicity, as measured by reduction in PCE/NEC ratios, was found in any treated group. Random variation around control values for
numbers of micronuclei was found at all sacrifice times and in both sexes of test animals. A singular statistically signif icant increase in micronuclei over concurrent control was calculated for the 400 mg/kg male group sacrificed at 72 hours (0.14 vs. 0.02). This increase was considered to be of no biological significance since it fell within solvent control ranges at other sampling times (notably 24 hours when optimally most of the micronuclei would be visualized).

Genotoxicity result: Negative

Cytotoxic concentration (if applicable): N/A

Results remarks: Positive controls were tested and produced the expected responses.

CONCLUSIONS

The test substance did not induce micronuclei in bone marrow cells of mice treated orally up to a nominal dose (800 mg/kg) considered a MTD by OECD (80% of the LD 50 ).

STUDY RELIABILITY

[2] Reliable with restrictions. Although the EPA’s limit dose in the absence of any toxicity (1000 mg/kg) was not assayed (represented by the LD 50 calculated in the range

- finding study), testing up to 800 mg/kg was sufficiently high to vali date the negative result obtained.

REFERENCES

Asquith, J. (1989b) Triazine Joint Venture: Mouse Micronucleus Test: Triazine: Toxicol Study No. M/MMN/10659. Unpublished study prepared by Toxicol Laboratories Ltd. EPA/OPP
MRID 41231701. As cited in an EP A OPP Data Evaluation Report by Irving Mauer, January
1990.

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED)
Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

82 Study 2: Micronucleus study in mice (Richardson, 1983)

Title: Evaluation of some formaldehyde

- release compounds and other biocides in the mouse
micronucleus test

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 75% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 25% not specified

Remarks: Referred to in the study report as Glokill 77 (75% pure, CA Reg. No. 56996

- 62

- 4).

METHOD

Method/guideline followed: Salamone, M.F. et al. (1981). Mutagenic activity of 41 compounds in the in vivo micronucleus assay. Progr. Mutation Res. 1:686

- 697.

Test type: Mouse bone marrow micronucleus test

GLP compliant?: Not indicated

Year study performed: 1983 (publication date)

Test species: Male C57Bl/6J mice, 6

- 8 weeks old, 8

- 10/sampling time

Metabolic activation: N/A

Doses tested: Two consecutive daily doses by intraperitoneal injection of 0 (vehicle not indicated) or 176 mg/kg

- bw. The latter dose represented 80% of the intraperitoneal LD 50/7 days (based on deaths occurring when animals wer e observed for 7 days following administration of a single i.p. dose). Mice were also dosed at 50% of the intraperitoneal LD 50/7 days , but the
micronucleus data were not evaluated for these animals.

Statistical methods used: The micronuclei results in t reated animals were analyzed for significant differences from controls using a one

- sided Student’s t

- test.

Test method/conditions remarks: For the study in which micronuclei were evaluated, mice were given two consecutive daily doses, 24 hours apart, usi ng dose levels equivalent to 80% of
the LD 50/7 days . Animals were killed at 24 or 48 hours after the second dose. Femurs were removed, bone marrow smears were applied to microscope slides, and cells were stained in Leishman’s stain. Slides were coded an d scored blind. Five hundred polychromatic erythrocytes (PCEs) were examined from each animal and the number containing micronuclei was scored. The ratio of PCEs to mature erythrocytes (ME) was also determined as a measure of cytotoxicity.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

83 RESULTS

Genotoxicity result: Negative

Cytotoxic dose: >176 mg/kg

- bw, the highest dose tested, based on absence of effect on the
PCE: ME ratio

Results remarks: A positive control, cyclophosphamide, was tested and produced the expected, significant increase in micronucleus frequency.

CONCLUSIONS

The test substance did not induce micronuclei in bone marrow erythrocytes of mice treated by two consecutive daily intraperitoneal injections (dose = 80% of the LD 50/7days) , 24 hours apart, followed by evaluation of micronucleus frequency at 24 or 48 hours after the second dose.

STUDY RELIABILITY

[2] Reliable with restriction. The study did not present evidence t hat the test substance produced signs of toxicity during the main study. The study did not indicate the vehicle used for the test substance (if any) or if control animals were injected i.p. with the vehicle. OPPTS 870.5395 (Mammalian Erythrocyte Micronuc leus Test) recommends that at least 2000 immature erythrocytes per animal should be scored for the incidence of micronucleated immature erythrocytes, whereas the current study evaluated micronucleus frequency in only 500 PCE per
animal.

REFERENCE

Richardson, C.R. (1983). Evaluation of some formaldehyde

- release compounds and other
biocides in the mouse micronucleus test. Mutat. Res. 124:241

- 246.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

84 D

- 9. Reproductive Toxicity

Summary of endpoint: Adequate

Although no reproductive toxicity studies were available, t he reproductive endpoint has been acceptably addressed on the basis that no effects on developmental endpoints were seen in an adequate oral developmental toxicity study in rats and no treatment

- related effects on the histology of reproductive organs of either sex were seen in adequate 90

- day oral and dermal toxicity studies in rats.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

85 D

- 10. Developmental Toxicity

Summary of endpoint: Adequate

Study 1: Developmental toxicity study in rats ( Ridgway, 1989)

Title: Triazine Rat Teratology Study

The study is: Adequate Not Adequate

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5%
unidentified

Remarks: Clear yellow fluid, referred to in the review as Grotan, Triazine, and hexahydro

1,3,5

- tris(2

- hydroxyethyl)s

- triazine

METHOD

Method/guideline followed: OPP 83

- 3

Test type: Developmental Toxicity

GLP compliant?: Yes

Year study performed: 1989 (issue date)

Test species: OFA

- SD(IOPS

- Caw) rats, 200

- 219 grams

Number of animals/sex/dose: 24 timed

- pregnant females

Route of administration: Oral gavage

Exposure duration: Daily on gestation days 6

- 15

Doses/concentrations tested: 0 (vehicle control), 250, 500, or 750 mg/kg

- bw/day

Vehicle: Deionized distilled water

S tatistical methods used: The significance level was set at p ≤ 0.05. ANOVA was followed by Student’s t

- test for analysis of maternal body weight, body weight gain, and food consumption, number of corpora lutea, number of live fetuses, implantation sites, and fetal body weights. The
Kruskal

- Wallis test was used for analysis of % pre

- and post

- implantation losses, fetal sex ratios, fetal malformations, and fetal variations. The percentage of fetus in each litter that showed eachFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

86 category of malformation and/or variation was calculate d, group means were calculated from litter means, and the results were compared using the Kruskal

- Wallis test.

Test method/conditions remarks: Females were time mated with males of the same strain and source. One male was caged with two females. The day on which the vaginal plug was seen, taken as evidence of mating, was designated day 0 of gestation. Pregnant females were then randomly assigned to dose groups. Analysis of dosing solution for concentration (times of analysis not stated) indicated that mean measured concentrations were 99.2

- 105% of target values and that the compound was stable in solution for 28 days.

RESULTS

One dam at 750 mg/kg

- bw/day was sacrificed on GD 14. Prior to sacrifice on that day the animal exhibited labored breathing, ra les, emaciation, piloerection, red staining around the mouth and nose, and pale extremities. All other animals survived the study.

Post dosing salivation was seen in females at 750 mg/kg

- bw/day. In dams at 250 and 500 mg/kg

- bw/day, rales, labored breath ing, wheezing, and tachypnea were observed occasionally in toward the end of the dosing period. No other clinical signs were reported.

At 750 mg/kg

- bw/day, maternal body weight gain (p<0.01) and food consumption (p<0.001) were significantly lower during the dosing period than in controls. Stomach lesions, characterized by ulceration and/or scarring of the mucosa, were observed in 14 of 20 females at 750 mg/kg

- bw/day, including the dam sacrificed on day 14. No gross abnormalities were reported in the oth er dose groups.

The data did not demonstrate any differences between the control and treated dams with respect to pregnancy rates, number of corpora lutea, implantation sites, number of live fetuses, or early and late resorptions. There were no abortions and no premature deliveries. In addition, those treatments did not produce evidence of developmental toxicity as measured by mean fetal weight or external or visceral, abnormalities. There were increased per

- fetus and per

- litter incidences of vestigial 14 th ribs and retarded ossification of the vertebral thoracic centra that appeared to be
dose

- related. However, since the increases were not statistically significant and the incidence of these abnormalities is highly variable in rats, the study authors and OPP reviewer did not
consider them to be treatment

- related.

Endp oint value(s): LOAEL (maternal toxicity) = 750 mg/kg

- bw/day based on decreased maternal body weight gain and ulcerations and/or scarring of the stomach mucosa; NOAEL = 500 mg/kg

- bw/day. LOAEL (developmental toxicity) > 750 mg/kg

- bw/day based on no effects at highest dose tested; LOAEL = 750 mg/kg

- bw/day.

Results remarks: None specifiedFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

87 CONCLUSIONS

The LOAEL for maternal toxicity was 750 mg/kg

- bw/day based on decreased body weight gain and ulcerations and/or scarring of the stomach mucosa and the NOAEL was 500 mg/kg

- bw/day

. The LOAEL for developmental toxicity was > 750 mg/kg

- bw/day based on no effects at the highest dose tested; the NOAEL was 750 mg/kg

- bw/day.

STUDY RELIABILITY

[2] Reliable with restrictions. There was no indication from the OPP re views that the study provided and analyzed certain developmental toxicity data (e.g., fetal weight, sex ratio) on a per

litter basis.

REFERENCES

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Ridgway, P. (1989) Triazine Rat Teratology Study: Reference No. LEF/8/89. Unpublished study prepared by Toxicol Laboratories Ltd. EPA/OPP MRID 41161801Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

88 E. SUPPLEMENTAL DATA (NON

- SIDS ENDPOINTS)

E

- 1

. Genetic Toxicity

– Other

Study 1: Unsched

uled DNA synthesis study in primary rat hepatocytes ( Curren, 1988)

Title: Unscheduled DNA Synthesis in Rat Primary Hepatocytes: Test Article: Hexahydro

1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4, test substance purity and composition not provided

Remarks: Viscous yellow liquid, referred to in the review as hexahydro

- 1,3,5

- tris(hydroxyethyl)

- s

- triazine, Grotan, and Bioban GK.

METHOD

Method/guideline followed: OPPTS 870.5550

Test type: Primary rat hepatocyte unscheduled DNA systhesis assay

GLP compliant?: Not indicated

Year study performed: 1988 (date report was issued)

Test species: Primary hepatocytes from male F344 rats

Metabolic activation: Without

Concentrations tested : Based on the results of a preliminary cytotoxicity study, nine concentrations ranging from 0.0001 to 1.0 μL/mL were tested.

Statistical methods used : Not indicated.

Test method/conditions remarks: For the assay to be considered valid, the following criteria must be satisfied: (1) the proportion of cells in repair in the solvent control group must be <15% and the net nuclear grain count of the solvent control group must be < 1.0; and (2) the positive control compound must induce a significant increase in the net nuclear grain count (≥ 5 grains/nucleus over th e negative control.

The assay was considered positive if the test material induced a concentration

- related increase in mean net nuclear grains and one or more of the doses had an increase in the mean net nuclear grain count that was ≥ 5 grains/nucleus ove r the negative control. In the absence of aFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

89 concentration

- related effect, a compound that showed nuclear grain counts that were ≥ 5 grains/nucleus over two successive concentrations was also considered positive.

RESULTS

In the preliminary cytotoxicity assay, ten concentrations (0.0003 to 10 μL/mL) of the test material were examined. The study author stated that the pH of the stock solution was adjusted to 7.4 with 1 N HC1 prior to dilution. However, there was a basic shift in the pH of cultures

treat ed with the two highest assayed levels (3.0 and 10 μL/mL) at initiation and termination of treatment. The study author further stated that the lactate dehydrogenase (LDH) value could not be obtained for the highest test concentration, presumably because o f test material interference with the LDH determination. Cytotoxicity, as indicated by increased leakage of LDH into the culture medium, did not proceed in a conventional concentration

- related manner. At the highest assayed concentration for which the LDH level could be determined (3.0 μL/mL), the percent relative cytotoxicity was 1%; however, as the concentration was reduced, cytotoxicity increased to 52% at 1.0 μL/mL and 66% at 0.3 μL/mL. Although the percent relative cytotoxicity at 0.1 μL/mL was 8%, t he microscopic evaluation of the hepatocyte cultures revealed a cytotoxic effect. Below this level, the test material was not cytotoxic.

Two UDS and parallel cytotoxicity assays were conducted with nine concentrations of the test material (0.0001 to 1.0 μL/mL). Because of unspecified technical difficulties, the first assay was
terminated.

In the repeat assay, the two highest test concentrations (0.3 and 1.0 μL/mL) induced marked cytotoxicity (85%) and were, therefore, not scored for UDS activity. The f ive levels selected for the evaluation of UDS induction were 0.1, 0.03, 0.01, 0.003, and 0.001 μL/mL. The highest test material concentration scored for UDS (0.10 μL/mL) induced a marked increase in the net nuclear grain count compared to the solvent cont rol. Similarly, the percentage of cells with ≥5 net nuclear grains was markedly higher at this level compared to the solvent control value. However, the evidence for a genotoxic effect was confined to the 0.10 μL/mL level. The mean net nuclear grain cou nts and percentage of cells with ≥5 net nuclear grains for hepatocytes exposed to 0.001, 0.003, 0.01, or 0.03 μL/mL of the test material, although higher than the solvent control, did not indicate a positive or a concentration

- related response. The study author concluded that hexahydro

- l,3,5

- tris(2

- hydroxyethyl)

- s

- triazine induced an equivocal response in this test system.

Genotoxicity result: Equivocal

Cytotoxic concentration (if applicable): 0.1 μL/mL

Results remarks: Responses to the positive cont rol were acceptable.

CONCLUSIONS

The test material is classified as presumptively genotoxic for induction of unscheduled DNA synthesis in this test system.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

90 STUDY RELIABILITY

[2] Reliable with restrictions. In the absence of a concentration

- related effect, confirmation of a “significant” increase at a single concentration is necessary to conclude a positive response in the UDS assay. However, the positive response was not co ncentration

- related, was limited to the
0.l0

- μL/mL level, and the results were not confirmed. In addition, the study author failed to provide information on test material purity, the batch number of the assayed sample, and analytical data to verify actual concentrations used in the assay.

REFERENCES

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED)
Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Curren, R. (1988) Unscheduled DNA Synthesis in Rat Primary Hepatocytes: Hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine: Study No. T8102.380. Unpublished study prepared by Microbiological Associates, Inc. EPA/OPP MRID 41262301.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

91 Study 2: Unscheduled DNA synthesis study in primary rat hepatocytes ( San and Raabe, 1993)

Title: Unscheduled DNA synthesis in rat primary hepatocytes

TEST SUBSTANCE

Identity: 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4, test substance purity and composition not provided

Remarks: Straw

- colored liquid, referred to in the review as hexahydro

- 1,3,5

- tris(hydroxyethyl)

-

s

- triazine and Grotan.

METHOD

Method/guideline followed: OPPTS 870.5550

Test type: Primary rat hepatocyte unscheduled DNA systhesis assay

GLP compliant?: Yes

Year study performed: 1993 (date report was issued)

Test species: Primary hepatocytes from male F344 rats

Metabolic activation: Without

Concentrations tested : Based on the results of a preliminary cytotoxicity study, nine concentrations ranging from 0.01 to 0.3 μg/mL were tested.

Statistical methods used : Not indicated.

Test method/conditions remarks: Following preliminary cytotoxici ty testing (by lactate dehydrogenase, LDH, release determinations), triplicate coverslip cultures (per does) of rat hepatocytes were exposed to hexahydro

- l, 3, 5

- tris(2

- hydroxyethyl)

- s

- triazine for 18

- 20 hours to
a series of nine concentrations of test art icle (ranging from 0.01 to 0.30 μg/mL), together with a constant concentration of tritiated thymidine (HTdr, 10 μCi/mL). Other cultures were treated with 7, 12

- dimethylebenz(a)anthracene (DMBA, 3 and 10 μg/mL), to serve as positive controls.

Fifty cell s per slide were read; net nuclear counts (NNC) were calculated (crude nuclear count less mean of three cytoplasmic counts) and were averaged for each treatment. In addition, the percentage of cells in repair was recorded for each test concentration. Mea ns, standard deviations and percent survival were computed. The grain count results represent unscheduled DNA synthesis

A test result was considered positive if the NNC in test substance

- treated cells was at least five
counts over the solvent control. C riteria for assay validity were not presented. The study authorFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

92 stated that conventional criteria for assessing assay validity and genotoxic responses were
followed.

RESULTS

The preliminary cytotoxicity test demonstrated that the test article produced c oncentration

related relative toxicities (based on LDH release) from >80% at 1.0 μg/mL down to 1% at 0.1 μg/mL. Hence, the HDT selected for the UDS assay itself was 0.3 μg/mL (at which related toxicity was 79%).

For the UDS assay, examination of the fixe d and stained cells which had been treated at concentrations of 0.15, 0.2, 0.25, or 0.3 μg/mL revealed that these could not be evaluated for UDS “because of excessive cytotoxicity”, resulting in relative cell survivals less than 35%. Although none of the remaining (lower) test article concentrations (0.01 to 0.1 μg/mL) caused an increase in mean NNC, according to the authors’ criteria established for declaring a positive result, there was a concentration

- related increase trend in both mean NNC, as well as percentage of cells showing DNA repair.

Genotoxicity result: Equivocal

Cytotoxic concentration (if applicable): 0.1 μg/mL

Results remarks: Positive controls produced an acceptable response.

CONCLUSIONS

The assay is considered equivocally positive based on slight, but concentration

- related, increases in both mean NNC and percentage of cells in repair at the highest three usable (i.e., non

- toxic) concentrations of 0.05, 0.07, and 0.10 μg/mL. However, results at these concentrations did not
reach the criterion for significance proposed by the investigators, namely, increase of ≥ 5 counts
over control.

STUDY RELIABILITY

[2] Reliable with restrictions. The study author did not provide information on test material purity, the batch number of the assayed sample, and analytical data to verify actual concentrations used in the assay.

REFERENCES

Chen, J.; Tao, J. (2008) Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

San, R.; Raabe, H. (1993) Unscheduled DNA Synthesis in Rat Primary Hepatocytes: Final Report: Lab Project Number: TC836.380: SPGT380. Unpublished study prepared by Microbiological Associates, Inc. EPA/OPP MRID 43020001.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

93 E

- 2

. Skin Irritation

Study 1: Dermal irritation study in rabbits ( Guest and Collier, 1985)

Title: Primary Dermal Irritation Test: Determination of the Degree of Primary Cutaneous Irritation Caused by Glokill 77 in the Rabbit.

TEST SUBSTANCE

Identity: 79.96% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triet hanol, CAS No. 4719

- 04

- 4; 20.04% unidentified (Chen and Tao 2008) or composition not indicated (Guest and Collier 1985)

Remarks: Clear colorless viscous liquid, referred to in the reviews as Glokill 77, HHT, hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, and dihydro

- 5

- (2

- hydroxyethyl)

- 1,3,5

- triazine

l,3(2H,4H)

- dipropanol

METHOD

Method/guideline followed: OPPTS 870.2500

Test type: Primary Dermal Irritation

-- Rabbit

GLP compliant?: Not stated

Year study performed: 1985 (issue date)

Test species: New Zealand White rabbits, 12

- 16 weeks of age

Number of animals/sex/dose: 12, sex not indicated

Route of administration: Dermal

Vehicle: None

Doses/concentrations tested: 0.5 mL, undiluted

Statistical methods used: None

Test method/conditions remarks: Glokill 77 (undiluted; 0.5 ml) was applied to clipped back skin of six young adult (12

- 16 weeks of age; no sex data given) New Zealand White rabbits. The test sites were occluded with a patch of surgical gauze and elasticized cor sets (Tubigrip), and exposure continued for 4 hours. Test sites were swabbed with cotton wool soaked in distilled water, and skin irritation was scored using a Draize method at 1 , 24, 48, and 72 hours after treatment. The test substance produced minimal erythema in three rabbits and minimal edema in one rabbit at one hour after dosing. However, these effects had disappeared at 24 hours post

-Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

94 dosing, and no other effects were observed throughout the 72

- hour study period. The calculated Primary Cutaneous Ir ritation Index was reported to be 0.0.

RESULTS

Endpoint value(s): Not irritating. Primary Irritation Index was 0.0. No erythema or edema was
seen from 24 to 72 hours.

Results remarks: None specified

CONCLUSIONS

The test substance was not irritating to rabbit skin.

STUDY RELIABILITY

[2] Valid with restrictions. Information is needed on the composition and stability of the test
substance.

REFERENCE

Chen, J.; Tao, J. (2008). Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Guest, R.L.; Collier, T.A. (1985). Primary Dermal Irritation Test: Determina tion of the Degree of Primary Cutaneous Irritation Caused by Glokill 77 in the Rabbit. Study Nos. 317/8505. Safepharm Laboratories Limited. EPA/OPP MRID 155986, as cited in Locke (1995).

Locke, R.K. (1995). H exahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- tria zine . Review of Toxicity Data.
DP Barcode: D212071. Submission #: S481738. Document No. 011557.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

95 Study 2: Dermal irritation study in rabbits ( Thomas, 1974)

Title: Glokill 77: Draize Skin Tests.

TEST SUBSTANCE

Identity: 79.96% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 20.04% unidentified (Chen and Tao 2008) or composition not indicated (Thomas 1974)

Remarks: Clear viscous liquid, referred to in the reviews as Glokill 77 (Batch No. K249), HHT, hexahydro

- 1,3,5

- tri s(2

- hydroxyethyl)

- s

- triazine, and dihydro

- 5

- (2

- hydroxyethyl)

- 1,3,5

- triazine

l,3(2H,4H)

- dipropanol.

METHOD

Method/guideline followed: OPPTS 870.2500

Test type: Primary Dermal Irritation

-- Rabbit

GLP compliant?: Not stated

Year study performed: 1974 (issue date)

Test species: New Zealand White rabbits [Note: According Table 3 of Chen and Tao (2008), the Guinea pig was the test species]

Number of animals/sex/dose: 4, sex not indicated

Route of administration: Dermal

Vehicle: Distilled water

Doses/concentrations tested: 0.5 mg/site or 5 mg/site from application of 0.5 mL of a 0.1 or 1% solution, respectively.

Statistical methods used: None

Test method/conditions remarks: Test material was applied to clipped and depilated intact abraded back skin of four New Zealand White rabbits for each concentration of dosing solution. The treatment sites were occluded with sterile gauze and exposure continued for 24 hours. After 24 hours of exposure , the patches were removed and the skin reactions on both the abraded and unabraded skin scored by a Draize scoring system. Additional scores were recorded at 72 hours post

- treatment.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

96 RESULTS

The 0.1% concentration was non

- irritating to intact skin and, on abraded skin, produced only mild erythema in one animal at 24 hours post

- treatment, which was absent at 72 hours after treatment. A concentration of 1.0% on intact skin produced only mild erythema in one animal at 24 hours after treatment, which was ab sent at 72 hours post

- treatment; on abraded skin, mild erythema was evident at 24 hours post

- treatment for all four animals, but this condition persisted only for one animal at 72 hours post

- treatment. Primary Irritation Indices were 0.06 for the 0.1%
solu tion and 0.44 for the 1.0% solution.

Endpoint value(s): Mildly irritating. Primary Irritation Indices were 0.06 for the 0.1% solution and 0.44 for the 1.0% solution.

Results remarks: None specified

CONCLUSIONS

The test substance was mildly irritating to rabbit skin.

STUDY RELIABILITY

[2] Valid with restrictions. Information is needed on the composition and stability of the test
substance.

REFERENCES

Chen, J.; Tao, J. (2008). Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicolog y Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Locke, R.K. (1995). H exahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine . Review of Toxicity Data.
DP Barcode: D212071. Submission #: S481738. Document No. 011557.

Thomas, M.B. (1974). Glokill 77: Draize Skin Tests. Study Nos. CL74:74:1024. Consultox Laboratories Ltd. EPA/OPP MRID 155987, as cited in Locke (1995).Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

97 Study 3 : Dermal irritation study in rabbits ( Siglin et al., 1989b)

Title: Acute Skin Irritation/Sensitization Studies with Busan 1060

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5%
unidentified

Remarks: Referred to in the study report as Busan 1060, HHT, hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, and 1,3,6

- triazine, 1,3,5(2H,4H, 6H)

- triethanol.

METHOD

Method/guideline followed: Not indicated.

Test type: Primary Dermal Irritation

-- Rabbit

GLP compliant?: Not stated

Year study performed: 1989

Test species: New Zealand White rabbit

Number of animals/sex/dose: 6, sex not indicated

Route of administration: Dermal

Vehicle: None

Doses/concentrations tested: 0.5 mg/site or 5 mg/site from application of 0.5 mL of a 0.1 or 1% solution, respectively.

Statistical methods used: None

Test method/conditions remarks: Animals received a single dermal application of Busan 1060 (neat) as a 4

- hour semi

- occluded exposure. Dermal reactions wer e evaluated by the Draize scoring system at 1, 24, 48, and 72 hours after treatment.

RESULTS

Very slight erythema and edema were observed at test sites of 3/6 animals at 1 hour after treatment. Irritation resolved completely by 24 hours post

- treatment.

Endpoint value(s): Mildly irritating. The Primary Irritation Index was 0.2/8Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

98 Results remarks: None specified

CONCLUSIONS

The test substance was mildly irritating to rabbit skin.

STUDY RELIABILITY

[2] Valid with restrictions. Information is needed on the composition and stability of the test substance, the study method, and the sex of animals on test.

REFERENCE

Siglin, J.C.; Rush, R.E.; Jenkins, P.K. et al. (1989b). Acute skin irritation/sensi tization studies with Busan 1060. In: R.A. Parent (ed.), Acute Toxicity Data, J. Amer Coll. Toxicol., Part B, Vol. 1, No. 3, 1992, pp. 203

- 204.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

99 E

- 3

. Eye Irritation

Study 1: Eye irritation study in rabbits ( Collier and Axelrad, 1984)

Title: OECD Eye Irritation Test: Determination of the Degree of Ocular Irritation Caused by
Glokill 77 in the Rabbit

TEST SUBSTANCE

Identity: 79.96% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 20.04% unidentified (Chen and Tao 2008) or composition not indicated (Collier and Axelrad, 1984).

Remarks: Clear Liquid, referred to in reviews as Glokill 77, HHT, hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, and dihydro

- 5

- (2

- hydroxyethyl)

- 1,3,5

- triazine

- l,3(2H,4H)

- dipropanol.

METHOD

Method/guideline followed: OPPTS 870.2400

Test type: Primary Eye Irritation

-- Rabbit

GLP compliant?: Not stated

Year study performed: 1984 (issue date)

Test species: New Zealand White rabbit, sex not indicated, 12

- 16 weeks old

Number of animals/sex/dose: 6

Route of administration: Ocular

Vehicle: None

Doses/concentrations tested: 0.1 mL

Statistical methods used: None

Test method/conditions remarks: None specified

RESULTS

Glokill 77 (undiluted, 0.1 mL) was instilled into the right eyes and irritation was scored by the Draize method at 1, 24, 48, and 72 hours after treatment.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

100 Endpoint value(s): The test substance was severely irritating (corrosive) to the eyes of all 6
rabbits. Effects at 72 hours included iritis, beefy

- red coloration of the conjunctivae accompanied by considerable swelling, copious discharge from the eye, and areas of complete corneal opacity.

Results remarks: None specified

CONCLUSIONS

The test substance was severely irritating (corrosive) to rabbit eyes.

STUDY RELIABILITY

[2] Valid with restrictions. Information is needed on test substance composition and stability.

REFERENCES

Chen, J.; Tao, J. (2008). Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Collier, T.A.; Axelrad, J.C. (1984) OECD Eye Irritation Test: Det ermination of the Degree of Ocular Irritation Caused by Glokill 77 in the Rabbit. EPA/OPP MRIDs 41675206; 155984. As cited in Locke (1995).

Locke, R.K. (1995). H exahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine . Review of Toxicity Data.
DP Barcode: D212071. Submission #: S481738. Document No. 011557.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

101 Study 2: Eye irritation study in rabbits ( Douds, 1995)

Title: Not provided

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5% unidentified inert ingredients.

Remarks: Clear, light yellow viscous liquid, referred to in the review as Grotan, hexahydro

1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine , and BD

- 024

- 3A.

METHOD

Method/guideline followed: OPP 81

- 4; OPPTS 870.2400

Test type: Primary Eye Irritation

-- Rabbit

GLP compliant?: Not stated

Year study performed: 1995 (report date)

Test species: New Zealand White rabbit, 2.832

- 3.363 g

Number of animals/sex/dose: 3

Route of administration: Ocular

Vehicle: None

Doses/concentrations tested: 0.5 mL

Statistical methods used: Not indicated

Test method/conditions remarks: None specified

RESULTS

The test substance (undiluted, 0.5 mL) was instilled into the conjunctival sac of “six pre examined” eyes and irritation was scored by the Draize method at 1, 24, 48, and 72 hours and on days 7, 10, 14, and 21, 2 after treatment.

Endpoint value(s): The test substance was severely irritating (corrosive) to the eyes of all 6
rab bits, with corneal opacity, unspecified effects on the iris, and redness, chemosis, and discharge of conjunctivae in 6/6 animals at 72 hours. The reviewer also noted sloughing of the corneal epithelium, vascularization of the cornea, raised areas on the c ornea, blanching of theFinal HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

102 conjunctivae, and hair loss around the eye (incidences of these effects were not provided in the review).

Results remarks: None specified

CONCLUSIONS

The test substance was severely irritating (corrosive) to rabbit eyes.

STUDY RELIABILITY

[2] Valid with restrictions. Information is needed on test substance composition and stability. The stated volume of test material instilled into the eye (0.5 mL) exceeded the volume recommended by OPPTS Guideline 870.2400 (0.1 mL). The OP P reviewer questioned the Quality Assurance statement provided by the testing laboratory; the reviewer noted that the only inspected in

- life portion of the study was indicated to be dose preparation, whereas it is “difficult
to understand how the dose need ed any preparation” because the study “used the liquid material as received.”

REFERENCE

Douds, D.A. (1995). Study title not provided. Springborn Report No. 3157

- 167, January 6,
1995. EPA/OPP MRID 435173

- 01. Data Review for Acute Eye Irritation Testing (§81

- 4).Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

103 E

- 4

. Skin Sensitization

Study 1: Dermal sensitization study in guinea pigs ( Thomas, 1974)

Title: Glokill 77: Guinea Pig Sensitization Test

TEST SUBSTANCE

Identity: 79.96% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 20.04% unidentified (Chen and Tao 2008) or composition not indicated (Thomas 1974)

Remarks: Clear viscous liquid, referred to in the reviews as Glokill 77 (Batch No. K249), HHT, hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, and dihydro

- 5

- (2

- hydroxyethyl)

- 1,3,5

- triazine

l,3(2H,4H)

- dipropanol.

METHOD

Method/guideline followed: OPPTS 870.2600

Test type: Dermal Sensitization

– Guinea Pigs

GLP (Y/N): Not stated

Species/strain: Hartley Guinea pigs, 300

- 400 g

Sex (male/female/both): Male

Number of animals/sex/dose: 6

Dose/concentration: Induction: 0.1 mL of 0.1% Glokill 77 in distilled water was injected intradermally every other day, using a different injection site for each treatment, for a total of 9 injections. Injection sites were scored for erythema and edema by the Draize method at 24 hours after each injection. Challenge Period: T wo weeks after final induction injection. Challenge dose: 0.1 mL of 0.1% Glokill 77 in distilled water, injected intradermally Control: The Draize scores resulting from the challenge dose were compared with those obtained during the induction phase to det ermine if sensitization had be induced.

Test condition: Not stated

RESULTS

All animals survived to study termination. Slight erythema and/or edema were noted in all animals after each of the induction injections. No greater edema and/or erythema was noted in any animal following the challenge injection than had been observed in the same animal following the induction injections.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

104 CONCLUSIONS

The test substance was mildly irritating but not a sensitizer to guinea pig skin.

STUDY RELIABILITY

[2] Reliable with restrictions. Information is needed on the composition and stability of the test
substance.

REFERENCES

Chen, J.; Tao, J. (2008). Hexahydro

- 1,3,5

- tris(2

- Hydroxyethyl)

- s

- Triazine: Toxicology Disciplinary Chapter for the Issuance of the Reregistration Eligibility Decision (RED) Document. Case No.: 3074. PC Code: 083301. DP Barcode: 346237. February 4, 2008.

Locke, R.K. (1995). H exahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine . Review of Toxicity Data.
DP Barcode: D212071. Su bmission #: S481738. Document No. 011557.

Thomas, M.B. (1974). Glokill 77: Guinea Pig Sensitization Test. Study Nos. CL74:74:1024. Consultox Laboratories Ltd. EPA/OPP MRID 155987, as cited in Locke (1995).Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

105 Study 2: Dermal sensitization study in guinea pigs (Siglin et al., 1989b)

Title: Acute Skin Irritation/Sensitization Studies with Busan 1060

TEST SUBSTANCE

Identity: 78.5% 1,3,5

- Triazine

- 1,3,5(2H,4H,6H)

- triethanol, CAS No. 4719

- 04

- 4; 21.5%
unidentified

Remarks: Referred to in the study report as Busan 1060, HHT, hexahydro

- 1,3,5

- tris(2

- hydroxyethyl)

- s

- triazine, and 1,3,6

- triazine, 1,3,5(2H,4H, 6H)

- triethanol.

METHOD

Method/guideline followed: Buehler, E.V.; Griffith, F. (1975). Experimental skin sensitization in the guinea pig and man. In: Animal Models in Dermatology, Maibach, H. (ed.), pp. 56

- 66.

Test type: Delayed contact sensitization (modified Buehler design)

GLP (Y/N): Not stated

Species/strain: Hartley guinea pigs, 301

- 428 g

Sex (male/female/both): Both

Number of ani mals/sex/dose: 5

Dose/concentration: Induction: 0.4 mL topical occlusive application of 10% w/v Busan 1060 in
distilled water once/week for 3 consecutive weeks. Challenge Period: Following a resting period of 2 weeks, the 10 induced animals received th e first challenge application; 7 days later, the animals were rechallenged. Challenge dose: 5% Busan 1060 in distilled water (volume not indicated) Control: Naïve irritation control groups received 5% Busan 1060 at week 2 (10 animals) or week 3 (a new grou p of 10 animals).

Test condition: Not stated

RESULTS

Similar dermal irritation scores were seen in control and induced animals at 24 hours after the initial challenge. By 48 and 72 hours after the initial challenge, the response in induced animals “generally appeared more severe.” Following re

- challenge, el evated irritation scores were seen in induced animals at 24 hours (7/10 animals) and 48 hours (3/10 animals) whereas minimal responses were seen in the naïve re

- challenge control animals at both times. [NOTE: Post

challenge scores are not presented here because they were not legible in Siglin et al. (1989).]Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

106 CONCLUSIONS

The test substance was considered to be a mild delayed contact sensitizer to guinea pig skin.

STUDY RELIABILITY

[2] Reliable with restrictions. Information is needed on the composition and stability of the test substance. The irritation scoring system was not characterized and irritation scores were not legible in the cited study.

REFERENCE

Siglin, J.C.; Rush, R.E.; Jenkins, P.K. et al. (1989b). Acute skin irritation/sensitization studies with Busan 1060. In: R.A. Parent (ed.), Acute Toxicity Data, J. Amer Coll. Toxicol., Part B, Vol. 1, No. 3, 1992, pp. 204.Final HPV 2 Data Adequacy Review (September 2012) CAS RN 4719

- 04

- 4

107 F. DATA ADEQUACY SUMMARY TABLE

Endpoint Study Information
Available Acceptable Data Gap

Aquatic Effects Acute Toxicity to Fish Yes Yes No Acute Toxicity to Aquatic
Invertebrates Yes Yes No

Toxicity to Aquatic Plants Yes Yes No
Health Effects Acute Toxicity Yes Yes No Repeated

- Dose Toxicity Yes Yes No
Gene Mutation Yes Yes No
Chromosomal Aberrations Yes Yes No Reproductive Toxicity No

-- No 1 Developmental Toxicity Yes Yes No

1 The reproductive endpoint has been acceptably addressed on the basis that no effects on developmental endpoints were seen in an adequate oral developmental toxicity study in rats and no treatment

- related effects on the histology of reproductive organs of e ither sex were seen in adequate 90

- day oral and dermal toxicity studies in rats.